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Abstract 
The tension between the increasing cost of healthcare provision and the need to 
provide a quality level of care to a rising number of people is a global phenomenon. 
A focus on one over the other could result in a rise in adverse patient outcomes, or 
a health system too costly to be sustainable. Clinical governance is an approach 
policymakers can use to walk the middle line of creating a healthcare service that 
meets quality of care standards in a cost-effective manner, as has been done in 
Australia, Burundi, Egypt, Spain, UK and Yemen (Goyet et al, 2019; Abd El Fatah et 
al, 2019, Mannion et al, 2015; Aguilar Martin et al, 2019). 
This study examines the practice of clinical governance in one LMIC setting that has 
been able to successfully do this balancing walk for 20 years. Understanding how 
this was done in the Western Cape province of South Africa helps inform how 
clinical governance can be used to continue adding value as the health system 
moves towards universal healthcare. 
A mixed methods qualitative design was used for data collection and involved  three 
phases: (1) a document review of all policies in the province to identify clinical 
governance structures; (2) observation of these structures in action, comparing 
lived to written experience of clinical governance; and (3) interviews with key 
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stakeholders in the province to get their perspectives on past, present and future 
forms of clinical governance. The Donabedian model was used to frame analysis 
into three dimensions of care, viz. structure, process and outcome. 
Beyond a comprehensive policy framework, collaborative structures and 
consultative leadership styles facilitated strengthened clinical governance. For 
example, clinical audits and M&E events become punitive and corrosive without 
communication and supportive relationships between colleagues. Family 
physicians have become the champions of clinical governance in a decentralized 
health system and when supported in this by policy and management, the quality 
of care in health systems thrive. 
Clinical governance is an effective strategy or tool LMICs can use to ensure quality 
of care is maintained or improved upon, even in resource-challenged settings. But 
while some structures, processes and outcomes may be borrowed from other LMIC 
or HIC settings, these need to be contextualized to local conditions. Appropriate 
clinical governance champions need to be identified and given the appropriate 
mandate. Human relationships are key to the successful implementation of 
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South Africa has undergone a significant change process since achieving 
democracy in 1994 and continues to do so as evidenced by the recent activity in the 
political, economic and social spheres. This has been a deliberate process in the 
case of the public health system, where the design and engineering of the system 
has had to evolve to meet the growing expectations of a newly-enfranchised 
population. 
 
While the vision of the future of the public health system is largely a unified one at 
national level, the way in which this is realised differs from province to province. It is 
up to the provincial Departments of Health to design, implement and evaluate how 
exactly change will occur on the ground to achieve this national vision. Looking at 
the differences in health outcomes between provinces twenty years later, it is 
apparent that not all provinces fared equally in improving the health status of their 
beneficiaries (Coovadia et al, 2009). The Western Cape stands out as one of the 
provinces that has been able to create sustainable and effective change. What 





Health systems are today recognized to be influential determinants of health 
(WholeSystSA, 2016). The ways in which they are designed, operated and financed 
can potentially create positive value for users, in the form of better health outcomes, 
enhanced system responsiveness, greater protection from social and financial risk 
for citizens and improved efficiency during service provision, as described in the 
WHO Health System Framework (WHO, 2007). 
 
 
Diagram 1: WHO Health System Framework 
 
“Leadership and governance” is a key building block in this framework, where the 
term is used to refer to the need for strategic goals, policies and plans that are 
sensitive to the needs of citizens; provide effective oversight, regulation and 
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accountability; and improve organisational capacity through the building of 
supportive coalitions and partnerships. 
 
Bevir (2013), defines governance as “all processes of governing, whether 
undertaken by a government, market or network, whether over a family, tribe, 
formal or informal organisation or territory and whether through laws, norms, power 
or language.” The focus is on social practices and activities that create value for 
stakeholders and how these are regulated, sustained and held accountable.  
 
In the context of the health system, clinical governance is differentiated from 
corporate governance, where the former refers only to those aspects that affect the 
delivery of care to patients and the latter to other operational activities. 
 
Clinical governance is a process first described in the United Kingdom (UK) in the 
late 1990’s, as a form of quality assurance, developed in response to inadequacies 
identified in the scope and quality of service provision in the UK National Health 
Service (NHS) at the time. The pressure to contain costs through clinical budgeting, 
resource management and medical auditing activities grew and the application of 
quasi-market competition ideologies to the health sector eventually led to breaches 
in the ability of the health system to provide quality care to all citizens (Flynn, 2002). 
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A need was identified to establish and maintain the standard of care provided, while 
at the same time managing the costs thereof. Clinical governance soon became 
viewed as a tool that could be used to support the safe improvement of cost 
efficiency within the health system without disrupting the provision of care (Buetow 
and Roland, 1999; Ferguson and Lim, 2001). 
 
But in a broader sense, clinical governance speaks to accountability for the quality 
and safety of healthcare. A 2013 review by Brennan and Flynn describes how its 
definition has evolved to now include: 
 
1. Processes to continuously monitor and improve the quality of care 
2. The creation of an organisational culture that supports safe, high-quality, 
patient-centered service provision 
3. Broader stakeholder involvement in leadership and management processes 
4. Increased accountability and responsibility for monitoring and oversight of 
clinical activities by stakeholders 
 
Stakeholders may include politicians, regulators (e.g. governments and 
professional bodies), governors (e.g. boards of directors), internal and external 
auditors, managers, clinicians, academics, patients and members of the public. 
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Organisational culture in this study refers to “the way things are done around here” 
as a result of shared elements such as languages, ideologies, beliefs, values and 
rituals (Davies et al, 2007; Deal & Kennedy, 1982; Pettigrew, 1979; Prenestini et al, 
2015). This bears a resemblance to Bevir’s definition of governance in that it speaks 
to the intangible elements that make up the social practices within an organisation. 
Theories on how organisational culture is created and sustained differ between 
contexts and the purpose of the organisation or program, but most contain some 
form of top-down and/or bottom-up diffusion of the elements listed above.  
 
In the case of organisational culture in the context of change management, the 
upper echelons theory proposes that the characteristics of top management 
strongly influence the attitudes and behaviors of personnel and the perspective of 
the organisation to strategic change. A health organisation, such as a private 
hospital group or a public health system, that undertakes to implement clinical 
governance practices as part of its program to maintain quality of care, commits to 
a change in the practice and scope of business which will impact on all strata of the 
organisation. Managing change in any organisation should be an active process if 
the desired outcomes are to be achieved with a degree of certainty. (Chaganti & 
Sambharya, 1987; Cameron, 1985; Gerowitz et al, 1996; Prenestini et al, 2015).   
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Gauld (2014) elaborates further on how a health system needs to adapt to changes 
brought on by clinical governance initiatives and the outcomes that can be achieved 
thereby. He found that systems that place clinical governance and leadership at the 
center of health policy observed significant improvements in performance across a 
range of cost and quality measures. In his opinion health professionals have the 
responsibility of both providing care and improving the system within which care is 
delivered, while governing boards and managers of health care organisations have 
the responsibility of ensuring both the quality of clinical service delivered and the 
financial sustainability of the facility or system. Key to the success of clinical 
governance initiatives is the migration of health professionals from clinical 
management to organisational management roles. 
 
As clinicians step into the organisational world, this potentially creates tension 
between seemingly inconsolable cultures, leadership styles and priorities, with the 
medical world leaning towards autonomy in decision-making and prioritizing 
patient care and the organisational world towards some form of collaborative or 
removed decision-making and prioritizing organisational efficiency. Denis & Ross 
Baker (2015), describe these competing logics as a dichotomy that must be 
traversed if health systems are to remain effective and sustainable.  
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Flynn states in his paper Clinical Governance and Governmentality, 2002, that while 
the degree of self-determination, self-surveillance and self-management required 
by clinicians to regulate clinical practice may be an essential aspect of the 
management of health risks, this style of leadership and governance conflicts with 
conventional organisational governance practices. In the latter, decentralized 
responsibility and centralized, and often hierarchical, control over strategy, 
resources and priority-setting are the norm and this fails to create a culture that 
welcomes and supports the integration of clinicians into leadership and governance 
roles.  
 
Conventional styles of governance, which may include quality assessment activities 
such as staff appraisals, quality audits and performance indicators, only serve to 
further extend formal centralized control and erode professional autonomy, while 
appearing to delegate and incorporate those charged with service delivery. 
 
He believes that a governance system based on the principles of “soft bureaucracy” 
is more accommodating of the unique characteristics of clinician leaders and 
“achieves legitimacy among professionals in an entrepreneurial and decentralized 
organisation” while still functioning with the more rigid forms of externalized 
legitimacy required by a centralized corporate, political or health system. 
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“Soft bureaucracy” is a term used by Courpasson in 2000, to describe “managerial 
strategies which are oriented towards the construction of political centralization, 
where processes of flexibility and decentralization co-exist with more rigid 
constraints and structures of domination.” He based this analysis on empirical 
studies into French political and business organisational structures. 
 
His subsequent analysis of clinician-led organisations that had successfully 
transitioned through the policy change process found that systems of self-
governance had evolved that contained characteristics drawing from both hard and 
soft organisational strategies, including: 
 
1. Clear assignation of responsibility, especially in cases of failure 
2. Orientation of behaviour by professionals to maintain their reputations 
3. Adoption of standardised criteria for performance by professionals while 
initiating and influencing their definition to preserve a grey area around the 
definition of success or failure 
4. The practice of some form of flexible cooperation, where control over 
autonomy is exchanged for recognition of expert effectiveness.  
 
This last point in particular is contrasted by Courpasson against what he terms “hard 
bureaucracy” strategies, borrowed by managers from the corporate world, that try 
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to exercise control by instrumentalising success and failure (e.g. performance 
appraisal tools) and objectifying responsibility, removing room for human error in 
ways very similar to the conventional practices described by Flynn above. 
 
“Soft bureaucracy” strategies build and sustain collaboration and partnerships 
between clinical and non-clinical stakeholders who share a common vision of 
improved health system performance. A shared vision in turn contributes towards 
the creation of a cohesive organisational culture that is more adaptable to policy 
change. The WHO, in its 2006 publication on quality of care, states that it is the 
connections and relationships between policy makers, health-service providers and 
communities and service users that facilitate clear definitions of roles and 
responsibilities and subsequently efficient implementation of clinical governance 
initiatives.  
 
Prenestini et al. (2015), found that, in the context of the Italian health system, clinical 
governance was shaped by the rapport that exists between (clinical and non-
clinical) members of the management team. In teams with a more cohesive rapport, 
a more positive outlook was observed towards clinical governance and the changes 
initiated in its pursuit, both within the team and in the organization at large. 
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They found that the creation of a supportive organisational culture that nurtures a 
shared perspective towards clinical governance among managers is an active 
process and calls for a series of active policy and management actions. The existing 
dominant culture needs to be identified, evaluated in terms of its ability to support 
new clinical governance policies and initiatives, and a change process initiated if it 
is found to be lacking. The future selection of top managers should also consider 
their leadership style and aptitude to grow and develop the appropriate culture. 
Existing managers and clinicians may require training to reinforce practices that are 
consistent with the desired organisational culture.  
 
Viitanen et al. (2015), during their examination of hospital management teams in 
Norway, found that in teams composed of individuals with divergent cultural 
backgrounds, communication and the free flow of information were stressed as 
critically enabling factors towards the creation of a unified and effective 
organisational rapport or team culture. And importantly, definitions of information 
included both content relevant to the operations of individual teams within the 
organisation as well as content that helped create a big picture overview of the 
organisations goals and directives. This helped individual managers and teams 
locate themselves and their teams within the larger health organisation. 
 
 20 
Lairumbi et al. (2012), in their review of clinical governance initiatives in high income 
settings, identified five additional factors that contribute to the success of clinical 
governance initiatives: 
 
1. The perception of complexity of clinical governance initiatives and its 
indicators among stakeholders 
2. The complexity of the system within which clinical governance is introduced, 
particularly in coordinating the differences in interests, power and influence 
of different stakeholders 
3. The level of engagement among stakeholders and whether this encourages 
convergent or divergent organisational cultures 
4. The level of engagement on the part of leadership to build connections 
between different stakeholders and create enthusiasm for, commitment to 
and engagement with clinical governance initiatives 
5. Whether organisations include the establishment of trust - “to do the right 
thing” - as a core tenet of clinical governance policies instead of relying only 
on measurement. 
 
While communication is not mentioned explicitly by Lairumbi at al. (2012) as a key 
factor, it is evident, as in Viitanen et al. (2015), that only with healthy and clear 
pathways of communication and collaboration between stakeholders will the 
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defined clinical governance initiatives be successful. Lazarus and France (2014) go 
further to position communication as a key enabler of all of the building blocks of 
the health system and not only leadership and governance, as demonstrated in their 
proposed adaptation of the WHO framework from diagram 2.  
 
 
Diagram 2: WHO Health System Framework, adapted by Lazarus and French (2014) 
 
Their definition of communication is broad, extending from the interpersonal to the 
digital, but the consensus is that this dimension is too influential not to be 
considered independently during any health system policy design or 
implementation process. (Lazarus & French, 2014). These are, after all, social 
practices in a health system setting, as described by Bevir (2013) above. 
 
 22 
In the planning or evaluating clinical governance initiatives, public and private 
organisations around the world tend to rely on a handful of models to structure 
these processes, borrowing from broader governance literature (Siddiqi et al., 
2008). These include the WHO’s domains of stewardship, the Pan American Health 
Organisation’s (PAHO) essential public health functions, the World Bank’s six basic 
aspects of governance and the United Nations Development Programme (UNDP) 
principles of good governance. The last is used by the Western Cape Department 
of Health (WCDoH) to frame its clinical governance initiatives and includes the 
principles in table 1 (as described in Graham et al., 2003) and diagram 3. 
 
Participatory All men and women should have a voice in decision-
making, either directly or through legitimate intermediate 
institutions that represent their intention. Such broad 
participation is built on freedom of association and 
speech, as well as capacities to participate constructively. 
Consensus Oriented Good governance mediates differing interests to reach a 
broad consensus on what is in the best interest of the 
group and, where possible, on policies and procedures.  
Strategic Vision Leaders and the public have a broad and long-term 
perspective on good governance and human 
development, along with a sense of what is needed for 
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such development. There is also an understanding of the 
historical, cultural and social complexities in which that 
perspective is grounded.  
Responsive Institutions and processes try to serve all stakeholders.  
Effective and Efficient Processes and institutions produce results that meet 
needs while making the best use of resources. 
Accountable Decision-makers in government, the private sector and 
civil society organizations are accountable to the public, 
as well as to institutional stakeholders. This accountability 
differs depending on the organizations and whether the 
decision is internal or external.  
Transparent Transparency is built on the free flow of information. 
Processes, institutions and information are directly 
accessible to those concerned with them, and enough 
information is provided to understand and monitor them.  
Equitable and 
Inclusive 
All men and women have opportunities to improve or 
maintain their well- being. 
Follows the Rule of 
Law 
Legal frameworks should be fair and enforced impartially, 
particularly the laws on human rights. 
 
Table 1: UNDP Principles of Good Governance (Graham et al, 2003) 
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Diagram 3: UNDP Principles of Good Governance (WCDoH, 2014) 
 
Health systems across the world, from national health systems in Ireland, New 
Zealand and Thailand, to privatized health systems such as the Kaiser Permanente 
or the Geisinger Health organisations in the USA (Denis & Forest, 2012), have 
adopted clinical governance policies as a means to circumscribe the potential risk 
to the quality and scope of patient care associated with efforts to improve the cost-
effectiveness of service delivery and to ultimately strengthen the health system.  
 
The systematic application of clinical governance initiatives has proven to 
strengthen the health system as a whole and not just impact on the elements of 
governance, quality and improved health (as laid out in the WHO model). In the UK, 
for example, the establishment of the National Service Framework and the NICE 
guidelines created a common set of standards all actors in the health system are 
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required to adhere and aspire to (Lairumbi et al., 2012). By clearly articulating policy 
and institutional arrangements, individual actors were more aware of how the 
desired changes impacted on their individual roles and responsibilities. This in turn 
had an impact on other building blocks and outcomes of health system 
strengthening activities, including levels of responsiveness, efficiency, service 
delivery and on the level of communication and cooperation within the health 
workforce in general.  
 
Lairumbi et al., 2012, in their review of existing clinical governance initiatives in 
HICs, also found that successful clinical governance initiatives required active 
assessment and management of the power relations between various clinical and 
non-clinical actors, strengthened leadership to facilitate implementation and an 
awareness of the complexity of the health system in order to anticipate possible 
problems and promote more stakeholder engagement. These all rely on a healthy 
level of communication and similarly speak to broader strengthening of the health 
system.  
 
While both high-income countries (HIC) and low- and middle-income countries 
(LMIC) run the gauntlet between providing quality service provision and 
maintaining cost-effectiveness, very little literature is published on how health 
systems in LMICs do so. This researcher found a 2015 primary survey of the Iranian 
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health system (Sadeghifar et al.) and a review of 16 case studies from LMIC settings 
on the role of governance in health workforce policy implementation (Dieleman et 
al.). The latter concluded that governance, while evident in its influence on health 
system change, was not explicit enough in policy and calls for more research “to 
better understand how governance influences…policy development and 
implementation.” The former found that most policy documents made mention of 
clinical governance initiatives but that it was mostly formulaic and that there was a 
lack of appropriate mechanisms to monitor, evaluate and reflect on past 
experience. 
 
This research will itself be located within a larger project, entitled WholeSystSA, 
which was a research project conducted by health systems researchers at the 
WCDoH, the University of Cape Town and the University of the Western Cape 
between 2015-2016. They sought to “understand the experience of health system 
transformation in the Western Cape” (WC) (CHESAI 2020). This project was inspired 
by the passing of twenty-two years since the end of apartheid and the question of 
how much had changed (in the context of the health system), especially for the most 
vulnerable and previously disadvantaged since the onset of democracy. (UK 
Research and Innovation, 2019) 
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Using a series of interviews, workshops and document review, WholeSystSA looked 
to identify enabling and constraining factors, including context, policies, processes 
and actors, within the WC health system that helped shape health system 
transformation in the province. This was done in order to better understand how 
past efforts gave rise to current achievements and how these may be used to inform 
future efforts to improve health care, the health system and the health of 
communities in both the Western Cape and broader South Africa. (Gilson et al, 
2017) 
 
The WC health system was chosen as the case province because of its reputation 
for having relatively effectively transitioned from serving the needs of the privileged 
during apartheid to serving the needs of the many in democratic South Africa. (UK 
Research and Innovation, 2019) Contrasting this against the national context 









3. Research Focus 
 
3.1. Research Problem 
 
As health systems expand to meet the growing needs of a growing population, 
often without a comparable increase in budget, the tension between cost-effective 
service delivery and the quality of service delivery becomes more apparent and 
poses a clear risk to the beneficiaries of the system. Clinical governance initiatives 
have been described in the literature as one means by which this risk can be 
reduced. But how are these initiatives are designed in low- and middle-income 
countries (LMIC) for sustainability and efficacy is not adequately described in the 
literature. 
 
Clinical governance has formed part of health system strengthening over the past 
20 years in South Africa and particularly in the province of the Western Cape, a 
consequence of initiatives with explicit clinical governance goals or a result of the 
pursuit of other system strengthening goals. How these outcomes were achieved, 





3.2. Research Questions 
 
1. How did clinical governance structures evolve within the Western Cape 
province over the past 20 years? 
 
2. How are these clinical governance structures operationalized and 
governed? 
 
3. What are the outcomes of clinical governance structures and what is their 
impact? 
 
3.3. Research Aim 
 
The WholeSystSA exploration of the activities of the WCDoH to strengthen its health 
system provide a valuable opportunity to observe clinical governance initiatives at 
play in-situ. It also provides an opportunity to observe them in a LMIC setting where 
health systems are particularly stressed by cost-cutting initiatives. The systemic 
challenges faced in the Western Cape are shared by other provinces within South 
Africa and other LMICs but the improvement in health indicators and service 
delivery differs to some degree. 
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This study makes use of the Donabedian model to frame the study on a macro level. 
This is a conceptual model that was first described by Avedis Donabedian, a 
physician and health services researcher from the USA, in 1966 and has since 
become the dominant paradigm used to examine governance and the practice of 
policy making in relation to health services and quality of care (Donabedian, 1988; 
McQuestion, 2006; McDonald et al, 2007). In the model, three dimensions of care 
are described, viz. structure, process and outcome, where: 
 
1. Structure describes the organizational structure and legal/policy frameworks 
in place to facilitate an intervention. 
2. Process denotes the relationships and flow of information between the 
structures, higher-level policy makers and lower-level managers, as well as 
between different stakeholders present within the structure itself. 
3. Outcomes refer to the intended impact of the structure or intervention on key 
measures of performance (who defines these KPIs?). 
 
This model is flexible enough to apply to the study of both the quality of healthcare 
within a single facility or a larger health system, as well as the underlying structure 








Using the above framework, this study proposes to: 
 
1. Describe the structure of clinical governance in the Western Cape, in terms 
of history and evolution. 
2. Understand the process of how these structures are operationalized and 
governed 
3. Assess and evaluate the outcomes of clinical governance initiatives. 
 
By studying the clinical governance activities in this province as a case study, this 
research will add to the understanding of how clinical governance activities need to 
be adapted to the unique environment of the developing world, ultimately 
contributing towards strengthening the health systems in these provinces and 






4.2. Data Collection 
 
This study employs a flexible design and iterative and concomitant cycles of data 
collection and analysis allow subsequent phases of the study to be informed by 
earlier phases. Four phases of data collection are planned: 
 
4.2.1. Phase 1 - Scoping Review 
 
To begin with, a scoping review of publicly available provincial policy documents 
such as Healthcare 2030, annual performance plans, annual District Health 
Barometers and published literature will be conducted to establish the range of 
clinical governance initiatives that have been planned and/or actioned within the 
province. The minutes of already identified clinical governance initiatives, e.g. 
GSAs, will also be sought out and added to the data set. Analysis will follow thematic 
guidelines using terms including “clinical governance”, “governance”, “quality”, 
“accountability”, “communication” and “collaboration”. 
 
The WholeSystSA project has already conducted a comprehensive review of policy 
and planning documents, evaluation reports and research reports on the WC health 
system. This study will crosscheck its data set against the WholeSystSA review and 
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borrow from and build on that foundation with a specific focus on clinical 
governance.  
 
There is a risk that the literature will not accurately describe or differentiate between 
contemporary and historical, theoretical and actual clinical governance initiatives. 
Should this scenario arise, the researcher may elect to begin with select key 
informant interviews, as described in Phase 3, during Phase 1 in order to improve 
his understanding of the policy and implementation environment. This will be 
conducted concomitantly to Phase 2 and continue into Phase 3. 
 
4.2.2. Phase 2 - Group Observation 
 
Once active clinical governance initiatives have been identified through the Phase 
1 review, the researcher will seek to directly observe the activities of a sample of 
these initiatives, e.g. observing a GSA meeting, in-situ. The intention is to gather 
data through both observer note-taking, reflexivity journals and the use of 
video/audio transcripts to understand further the structure, process and outcomes 
of functioning clinical governance initiatives and to compare these with the plans 
for such activities laid out in the policies reviewed in Phase 1. The researcher 
acknowledges that legal and administrative guidelines may preclude the use 
recording devices and will be guided by WCDoH precedent.  
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While the activities selected to be observed will be limited by time and resources, 
the intention is to observe at least one initiative in the Cape Town Metro district and 
one outside this district, each at least on one occasion. Other less formal meetings 
will also be included to further understand the broader cultural perspective towards 
clinical governance, e.g. a regular meeting of specialist anaesthetists identified 
through personal networking. The researcher plans to triangulate these against the 
findings of the Phase 1 review to assess for differences based on location and 
positioning (local, district, provincial) within the health system.  
 
Participant observation is a form of direct observation data collection whereby the 
researcher gathers data about the culture and behaviour of groups or individuals 
through passive, non-intervening, naturalistic observation (Zechmeister et al, 2009) 
but the researcher will eschew non-participatory in favor of passive participation 
because of the nature of the group structures – meetings take place in small office 
boardrooms where the researchers presence will be obvious and engagement to 
some degree with those being observed inevitable.  
 
Passive participation calls for the researcher to play a bystander role as opposed to 
non-participation that calls for no contact with the population or field of study. 
Limitations may include difficulty establishing rapport or adequate immersion in the 
field (Spradley, 1980). The aim is to systematically record the behaviour and 
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activities of participants during clinical governance activities such as a GSA meeting 
to better understand the structure, process and outcomes of these activities as well 
as to understand the behaviour of individuals towards these activities.  
 
Observer note taking and post-observation reflective journaling, along with 
potential transcripts of audio/video recordings, will be coded using a schedule 
created during the Phase 1 review and the results analyzed using a thematic 
approach. The findings of the transcripts will be triangulated with the reflective 
journal and observation notes as well as the findings of the Phase 1 review. 
 
4.2.3. Phase 3 - Key Informant Interviews 
 
The third level of exploration is a series of semi-structured interviews with key senior 
managers in the WCDoH, who will be initially purposively selected from those who 
participate in the clinical governance activities under observation in Phase 2 and 
stratified by position (provincial vs. district level, primary vs. tertiary care), work 
experience, background (administrative and clinical) and the type of clinical 
governance activity participated in (GSA vs. some other form of activity). Further 
interviewees will be recruited through a snowballing process. The target number of 
interviews is 20, more if time and resources allow, less if saturation is reached earlier.  
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The findings of the preceding two phases will be used to generate and frame an 
interview guide from whence the interview will set out, with the aim being to garner 
further insight into the structure, process and outcomes of clinical governance 
initiatives at play.  
 
The interviews will take place in the offices of participants to facilitate ease of access 
and audio/video recordings will be made to aid with transcription, carried out by 
the researcher. Coding and analysis will also make use of analyses of previous 
phases of this study as well as the Donabedian model and the Competing Values. 
Participants will be offered the option to have their participation in this study 
anonymized during the consent process preceding the interview. 
 
4.3. Data Analysis 
 
Post-field work data analysis will be continuous and iterative, using the Donabedian 
framework described above to guide the process of data analysis after each phase 
of investigation. The findings of preceding phases will contribute to the 
methodology of subsequent phases, as described above. 
 
Data will be coded using a code book developed during Phase 1 and added to 
during subsequent phases. Thematic analysis will be used to identify common 
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themes around clinical governance, organisational culture, quality control, 
accountability, communication and collaboration. The findings from the policy 
documents, which lay out what the WCDoH intends to do, will be compared to the 
findings of the observation and interview phases, which is what has actually 
manifested, and the difference between the two will be assessed in terms of how it 
has influenced the levels of quality and cost-efficiency within the WCDoH. Has the 
policy-implementation gap helped or hindered these outcomes? What are the 
important elements to hold on to from policy? What can be surrendered? What 
elements have not been described in the policy but has been essential to the 
realisation of the outcomes measured? 
 
The data collection-analysis-data collection cycle will continue until information 
saturation has occurred and a greater understanding is gained about how clinical 
governance is planned into policy, how these activities are actioned, what 
organisational cultural norms surrounds these initiatives and the impact of these 
initiatives on quality control and broader organisational culture. Primarily, this 
research seeks to understand the role of implemented clinical governance 
initiatives in the WCDoH on levels of quality of care in the province but will also seek 




4.4. Data Management 
 
The results of the Phase 1 survey, notes and transcripts from the Phase 2 
observations, transcripts from the Phase 3 interviews and responses from the Phase 
4 questionnaires will be in English and will collectively be accessible only to the 
researcher and senior WholeSystSA team members. The researcher will also act as 
data manager. This data set will be kept in safe storage by the researcher and 
backups will be made and stored in a second location. Original 
recordings/questionnaires will be destroyed once the study is complete to protect 
confidentiality, with only anonymous forms of the data set remaining for future 
analysis should the participant have elected to have his/her data anonymised 
during the consent process. 
 
4.5. Reflexivity and Ethics 
 
The researcher is a qualified medical doctor with 10 years of experience in the 
public and private health sectors of South Africa and the UK. This affords him the 
ability to identify with the needs and challenges faced by clinicians as they transition 
from the clinical to the administration spheres. He holds an MBA from the University 
of Cape Town where his focus was on leadership and governance. His knowledge 
of and experience in using qualitative research methodology to explore the 
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software issues of communication, relationships and change management in 
leadership structures in the health system will be useful in understanding the layers 
of interconnectivity and overlap inherent in the study of clinical governance 
initiatives in the WCDoH. 
 
Informed consent for phases 2 and 3 will be sought from both the WCDoH and all 
individual participants at the beginning of each phase. Participation will be entirely 
voluntary. Participants will be given the opportunity to withdraw or have their 
contribution to the study transcripts removed at any stage of the study. No 
remuneration will be paid. Once provincial ethics approval has been granted there 
may be some degree of coercion present in getting employees of the WCDoH to 
participate because of employment contracts. This will be mitigated to some 
degree during the informed consent process. 
 
At the beginning of each in-depth semi-structured interview a discussion will be 
held on the conditions for confidentiality and trust, and what would necessitate a 
breach of that confidentiality. The reasoning for recording the interviews need to 
be explained and criteria for when it would be possible to switch the equipment off 
will be shared at the onset of each interview. The data management protocol will 
be shared with participants. A similar process will be followed for observation of 
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clinical governance activities like the GSA meeting but will be guided by WCDoH 
protocol for researcher interaction with departmental procedures. 
 
The intentions of the study will be expressed clearly and simply, in the language of 
choice, at each interaction with the study sample. The name and contact details of 
the researcher will be provided to the participants. Participants will be given the 
opportunity to withdraw at any stage of the study and will have access to avenues 
of discussion to address any problems or complaints they noted during their 
interaction with the study.  
 
Feedback for each phase will be provided in the form of summated findings to 
participants of that phase in electronic format and if time and opportunity allows, 
these findings will be presented to the clinical governance groups/meetings the 
study has observed during Phase 2. 
 
Ethical approval will be sought for this study through the ethics approval board of 
UCT as well as from the ethics structure of the WCDoH. Consideration has been 







If adherence to the guidelines described in the Healthcare 2030 forms part of a 
manager’s job description, admitting to deviations from them may lead to 
disciplinary repercussions, which may prejudice some participants against 
engaging with the research at all or being open about their or others’ experiences. 
This will be mitigated by the ability to anonymize information gathered and will be 
offered to all participants. 
 
There are no direct benefits to the participants. Indirect benefits include accruing 
insight into individual belief systems and obstacles to their relationship with clinical 
governance as well as the health system in general. This will ultimately lead to an 




Benefits include successful completion of the study and helpful insights gained into 
clinical governance, policy implementation, and the role of communication and 
collaboration in health system strengthening. This may lead to further research or 
to policy. Insights garnered may also contribute to greater self-understanding in the 
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researchers leading to improved levels of interpersonal communication and 




The principles of rigor will be applied as follows: 
 
1. Purposive sampling is employed during all four phases of data collection.  
2. The researcher undertakes to assess for and minimise observer bias through 
validating his findings from the phase 2 observation and data analysis 
processes with his research supervisor and the interviewees in phase 3. 
3. During phase 3, interviews will be conducted in English as managers are 
required to have a working knowledge of the language to perform their 
duties. Should the researcher find that the interview findings are being 
compromised by the choice to conduct them in English, the interviewees will 
be offered the opportunity to respond in a language of their choice and the 
transcripts will be anonymised and translated before analysis. 
4. Data sets are triangulated in terms of both data sources and data analysis. 
Findings from the qualitative review will frame and inform the subsequent 
qualitative group observations and interview processes. Findings from the 
document review framed and informed the subsequent qualitative 
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observation and interview processes. The findings of the qualitative interview 
phase were used to interpret and add context to the results of the document 
review and observation phases. Theoretical triangulation is also employed 
during analysis to support rigor and credibility. 
 
5. Limitations of Study Methodology 
 
The researchers clinical background may bias him as he seeks to understand the 
nature of the relationship between clinicians and administrators in clinical 
governance activities. This may also influence the willingness of clinician or non-
clinician participants to share information. This will need to be considered during 
analysis.  
 
His positivist education may bias his analysis of the data and the subsequent 
application of the use of theory in creating understanding from it. This will be 
mitigated to some degree by his more relativist personal philosophy. 
 
The study is largely reliant on theory developed in HIC and largely takes place in 
urban environments. The implementation of clinical governance policies is 
contextual and the influence of LMIC and non-urban settings on outcomes will need 
to be considered during analysis. The attempt to include at least one clinical 
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governance activity from outside the Cape Metro district, should time allow, 




A summary of the findings of this study will be electronically shared with all 
participants of this study. Feedback will also be provided in the form of a 
presentation to the clinical governance groups, forums and meetings identified and 
observed during Phase 2 as well as to managers and policy makers to facilitate ease 
of understanding. This will be done by reporting the findings of the thematic 
analysis as well as a detailed audit trail to ensure reliable and verifiable reporting. 
The aim of this form of dissemination will be to inform future policy design around 
clinical governance and organisational culture and to inform managerial decisions 
in practice. The study design and results will also be documented in a series of 
journal-ready articles for submission to a range of local and international peer-
reviewed journals, including Health Policy and Planning, Journal of Public Health 
Policy, BMJ Quality and Safety, Journal of Health Economics, the International 








1 2 3 4 5 6 
Phase 1 
Review 
      
Phase 2 
Observe 
      
Phase 3 
Interview 
      
Phase 4 
Analyse 







Part B: Literature Review 
 
Topic: Clinical Governance as a tool for Health System Strengthening in LMICs 
 
1. Introduction and Objectives 
 
The objective of this literature review is to explore the definition and meaning 
assigned to the terms “Clinical Governance” (CG) and “Heath System 
Strengthening” (HSS) in contemporary literature and to examine the intersection of 
the two, particularly in low- and middle-income countries (LMICs). The researcher is 
looking to understand the value CG can add to HSS activities, especially in primary 
care (PC) settings. 
 
This review is intended to inform primary research conducted by the researcher, 
evaluating 22 years (1994 - 2016) of CG policy and action in the Western Cape 
Provincial Department of Health (WCDoH) in South Africa. This research is itself 
located within a larger project, entitled WholeSystSA, which sought to “understand 




This researcher seeks to understand the role CG played in this transformation 
process and how it can be used to further support HSS activities in the future. He 
interviewed key actors in the WCDoH on the topic of CG policy and implementation, 
observed CG in action and reviewed past WCDoH policies. The results of his 
empirical research follow in Part C of this dissertation. 
 
Understanding CG as a tool in HSS in LMICs is particularly important now as the 
South African health system navigates the process of implementing Universal 
Health Coverage (UHC) and the adoption of a unified National Health Insurance 
(NHI) financing model - a significant change from the two-tiered public- and private-
model currently at play (Health Policy Project, 2016). In the published NHI White 
Paper, the South African government places CG at the core of both (1) improving 
and maintaining the quality of care to citizens, (2) the selection of service providers 
and (3) the bouquet of services covered (The Republic of South Africa, 2017). 
 
Regarding the selection of service providers, the NHI White Paper specifically states 
that individual health care service providers will be assessed against indicators of 
clinical governance, in place of perceived quality of service assessments, to 
determine their eligibility for accreditation by the NHI Fund and thus participate in 
the health care provision marketplace. 
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Health care facilities will also have to meet a set of quality improvement initiatives in 
order to retain the ability to provide services to patients. These are documented in 
the National Quality Standards for Health (NQHS) (PHISA, 2019), where “Patient 
Safety, Clinical Governance and Care” is described as one of seven core domains, 
with “Patient Rights,” “Clinical Support Services,” “Public Health,” “Leadership and 
Corporate Governance,” “Operational Management” and “Facilities and 
Infrastructure” being the other six. The NHI White Paper calls for the Office of Health 
Standards Compliance (OHSC) to continue its role of health facility accreditation 
and monitoring but using this new tool to assess facilities against. 
 
The bouquet of services offered will also have to adapt to the merger of public and 
private sectors, with further focus on building a stronger primary health care (PHC) 
service that covers all citizens. In the current private sector, patients are routinely 
over-serviced, e.g. c-section rates of 68% in the private sector compared to 18% in 
the public sector. The NHI White Paper speaks to using CG protocols and 
population data to help determine the bouquet of services matched to the needs 
of the community being served. 
 
CG is set to become a key element of the envisaged integrated health system and 
a determinant of its success. The better policy makers, clinicians and administrators 
within the health system understand what CG means and how to utilize it, the better 
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prepared they will be to ensure a stronger, more accountable and more responsive 
health system is realized. 
 
2. Literature Search Strategy 
 
This review takes the form of a rapid scoping review, which shares components with 
a systematic review but is simplified to allow the review to be conducted in a timely 
manner. (Tricco et al, 2017). It is a form of knowledge synthesis that can be used to 
examine a broad range of literature and identify gaps and opportunities for further 
research (Arksey and O’Malley, 2005). 
 
The review began with a search of Google Scholar, EbscoHost and PubMed as the 
three primary electronic platforms for gathering published literature. Both empirical 
research, reviews and commentaries were included. 
 
Limitations included articles published in English only and between 2010 and 2019, 
unless particularly relevant literature fell outside of this search period. This time 
period was initially selected to allow for the most recent arguments presented in 
published literature to be identified and considered. But this was not fixed, 
particularly where an area needed further investigation and this was only supported 
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through engaging with literature/documents published before 2010. Policy 
documents from the WCDoH from pre-2010 were included in this research. 
 
Articles were screened by title and abstract during initial selection and assessment 
for selection bias was conducted by the researcher at this stage. Full-text screening 
was conducted at a second occasion before inclusion in the cohort for this review. 
A limitation is the absence of a second researcher to review the selected articles 
independently for bias. 
 
Key inclusion terms used included the following: 
 
- Clinical Governance 
- Health System* 
- LMIC* 
 
*  signifies that in addition to the search including references to “health system” and 
“LMIC”, it also included permutations beginning with the term in inverted commas 
and ending with an additional word or phrase. For example, this search included 




This review serves to inform research being conducted in South Africa - a LMIC with 
a unique set of characteristics not shared by non-LMIC countries. Much of the work 
on CG comes out of the UK and USA. Therefore LMIC* was a term used to refine the 
search for articles most appropriate to this review. However, this is still a 
comparatively under-researched area and articles from outside the LMIC setting 
were also considered when necessary to add depth to the understanding of the role 
of CG in HSS. 
 
CG and HSS are also two fields of research with growing bodies of work but it is the 
intersection between these two that is of interest in this review and this results in a 
further limitation to the number of documents available to the researcher. 
 
A secondary selection process involved the “backward” and “forward” approach 
recommended by Wester & Watson, 2002, where the citations of the articles 
selected above were also evaluated for pertinent articles to include in this review. 
 
Finally, a broader Google search was conducted to identify grey literature, 
including the WCDoH website for policy documents, annual reviews and other 
published material. The search for additional literature was stopped once the 
researcher had exhausted the databases for publications. 
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3. Summary and Interpretation of the Literature 
 
3.1. What is Clinical Governance? 
 
Scally and Donaldson, in the context of the United Kingdom (UK) National Health 
Service (NHS), describe CG as “a framework through which NHS organisations are 
accountable for continually improving the quality of their services and safeguarding 
high standards of care by creating an environment in which excellence in clinical 
care will flourish.” (Healthcare Improvement Scotland, 2018; Macfarlane, 2019; 
Halligan & Donaldson, 2001) 
 
CG is differentiated from corporate governance, where the former refers to those 
aspects that affect the delivery and quality of care to patients and the latter to other 
operational activities that make the practitioner-patient interface possible. 
 
The history of CG begins in the late 1980’s, after a series of highly-publicised 
breaches in patient safety, most notably the Bristol Inquiry into children’s heart 
surgery between 1984-1995 (UK Department of Health, 2001), which were put down 
to interplay between increases in patient numbers and their healthcare needs, 
increasing patient willingness and ability to communicate what they required from 
the health system, increasing healthcare costs and increasing medicolegal litigation 
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(Braithwaite & Travaglia, 2008). Reforms were required and CG and the idea of 
involving clinicians in quality reforms and clinical governance took root. 
 
This began in the form of a non-legislated “medical audit” activity, self-administered 
by doctors working in the NHS, assessing the quality of their daily clinical practice 
(Background and overview of Clinical Governance, 2002). In 1993, “medical audits” 
were turned into “clinical audits” when it was realized that other practitioners 
besides doctors were involved in delivering clinical services, e.g. nurses. 
 
While “clinical audit” activities were well funded and regularly undertaken in 
departments and facilities across the NHS, they remained non-legislated and there 
was no statutory obligation on practitioners or the facilities in which they worked to 
do anything to improve the quality of clinical care provided to patients. Problems 
were identified but little or no resources were allocated to correcting them. 
 
This was largely due, at the time, to the competitive, free-market healthcare system 
at play, which in turn put the pressure on decision makers and clinicians to contain 
costs through clinical budgeting, clinically insensitive resource management and 
non-binding clinical auditing activities. This system was not driven by the desire to 
improve the quality of care and service to patients (Flynn, 2002). 
 
 54 
But this changed in the late 1990’s. Scally and Donaldson published their paper on 
CG in 1998, introducing the concepts of accountability and continuity to quality 
improvement activities. And in 1999, the new UK Labor government introduced the 
new Health Act, making quality of care a statutory responsibility of the management 
teams of facilities through their CEO, equal in importance to financial profitability, 
and using CG as the framework through which quality of care can be improved and 
maintained (Background and overview of Clinical Governance, 2002). 
 
A 2013 review of CG literature by Brennan and Flynn expands on the original 1998 
definition of CG, describing how it has evolved to now include: 
 
1. Processes to continuously monitor and improve the quality of care, 
2. The creation of an organisational culture that supports safe, high-quality, 
patient-centered service provision, 
3. Broader stakeholder involvement in leadership and management processes, 
4. Increased accountability and responsibility for monitoring and oversight of 
clinical activities by stakeholders. 
 
Processes begin with the routine gathering of data through monitoring activities 
that are used to feed clinical indicator models tailored to the nature of the health 
system being observed - indicators used in the UK health system differ from those 
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used in more developing countries like Iran and South Africa (Azami-Aghdash et al, 
2015). Trends in these indicators are then used to improve or maintain quality of 
care. However, processes extend beyond monitoring and evaluation of clinical 
“service provision” activities. 
 
They include (1) creating and sharing job descriptions and responsibilities relating 
to CG activities with staff across the organisation, (2) managing CG-related 
knowledge and sharing information through open disclosure, (3) promoting 
evidence-based practice and continuous education, (4) managing practitioner 
experiences - risk exposure, note taking/reporting, performance reviews and 
adverse incidents, (5) managing patients experiences - informed consent, focus on 
patient safety, encouraging participation in the decision-making process and 
effective complaint management, and (6) ongoing accreditation of practitioners, 
facilities, clinical guidelines, technologies and operational processes that impact on 
clinical service delivery (Braithwaite & Travaglia, 2008). 
 
Vanu Som, 2004, expands on the above by stating that all levels of a healthcare 
organisation need to be included in CG processes if improved healthcare service 
delivery is to be achieved. This ranges from front-of-house staff (e.g. receptionists 
and data capturers) to back-end staff (e.g. cleaning staff and catering staff), clinical 
service providers (nurses, doctors, etc.) to management (ward- and organisation-
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tier management). Modern healthcare organisations are very complex and the 
greater the complexity, the greater the need for a coordinated, multi-disciplinary 
approach to improving the delivery of care. 
 
This also speaks to the second and third points of Brennan and Flynn’s definition, 
relating to organisational culture and stakeholder involvement. While Brennan and 
Flynn included the above-mentioned stakeholders from inside an organisation or 
healthcare facility in their definition of stakeholders, they extend their definition to 
include stakeholders from outside the organisation or facility. This may include 
politicians, regulators (e.g. governments and professional bodies), governors (e.g. 
boards of directors), internal and external auditors, academics, patients and 
members of the public - anyone impacted by, and/or with influence over, the way 
in which care is provided and the quality thereof. 
 
With this many stakeholders involved, it is imperative that a unified approach to CG 
is shared, even if the specific responsibilities assigned to individual stakeholders 
differs in scope, practice and accountability. This is facilitated by a shared definition 
or understanding of CG and a shared organisational culture that fosters the 
common goal of safe, high-quality, patient-centered service provision. 
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Organisational culture in this study refers to “the way things are done around here” 
as a result of shared elements such as languages, ideologies, beliefs, values and 
rituals (Davies et al, 2007; Deal & Kennedy, 19823; Prenestini et al, 2015). This bears 
a resemblance to Bevir’s (2013) broader definition of governance, which describes 
it as “all processes of governing, whether undertaken by a government, market or 
network, whether over a family, tribe, formal or informal organisation or territory 
and whether through laws, norms, power or language.” The various stakeholder 
tiers in the Brennan and Flynn’s definition mirror Bevir’s list of spheres of influence 
in his governance model.  
 
Bevir also speaks to the intangible elements that make up the social practices within 
an organisation, how these create value for stakeholders and how these are 
regulated, sustained and held accountable. 
 
Theories on how organisational culture is created and sustained differ between 
contexts and the purpose of the organisation or program, but most contain some 
form of top-down and/or bottom-up diffusion of the shared elements described 
above. One such theory is the upper echelons theory, which proposes that the 
characteristics of top management strongly influence the attitudes and behaviors of 
personnel and the perspective of the organisation to strategic change. A health 
organisation, such as a private hospital group or a public health system, that 
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undertakes to implement clinical governance practices, as part of its program to 
improve and maintain quality of care, commits to a change in the practice and scope 
of business which will impact on all strata of the organisation. Managing change in 
any organisation should be an active process if the desired outcomes are to be 
achieved with a degree of certainty. (Chaganti & Sambharya, 1987; Cameron, 1985; 
Gerowitz et al, 1996; Prenestini et al, 2015). 
 
Witter et al, 2019, through their review of HSS publications, show how engaging 
with stakeholders not traditionally included in a decision-making forum, e.g. civil 
participation, potentially has a positive impact on improvements in quality of care. 
The culture of an organisation or health facility extends beyond the employees 
within the organisation and the involvement of communities affected by changes in 
quality levels in creating a culture supportive of improved CG practices increases 
accountability within the organisation and helps improve patient expectations and 
satisfaction levels (West, 2001). 
 
But how to move from the theoretical to the practical? How do organisations go 
about implementing CG policies? Vanu Som (2004) expands on this by applying a 
modified version of the Donabedian model to expand CG policy into the three 
dimensions of the model, viz. (1) Structure, (2) Process and (3) Outcome plus an 
additional dimension of (4) Input. The Donabedian model was first described in 
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1966 by Avedis Donabedian, a physician and health services researcher from the 
USA and has since become the pre-eminent model used to examine governance 
and the practice of policy making in relation to health service delivery and 
managing quality of care. (Donabedian, 1988; McQuestion, 2006; McDonald et al, 
2007). 
 
In the model, three dimensions of care are described, viz. structure, process and 
outcome, where: 
 
1. Structure describes the organizational structure and legal/policy frameworks 
in place to facilitate an intervention. 
2. Process denotes the relationships and flow of information between the 
different levels of management within an organisation, as well as between 
intra- and extra-organisation stakeholders. 
3. Outcomes refer to the intended impact of the CG interventions on key 
measures of performance, as defined by the stakeholders involved. 
 
This model is flexible enough to apply to the study of both the quality of healthcare 
within a single facility or a larger health system, as well as the underlying structure 
and process that lies upstream of service provision. 
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Table 1, below, displays the inputs, structures, processes and outcomes as 
described in the CG review by Vanu Som (2004) which serve as a starting point for 
stakeholders to consider when crafting CG policy and implementation strategies for 





INPUT Financial resources (additional commitments, new 
investments) 
Infrastructure (new buildings, equipment, etc.) 
Human resources (creation of new posts: CG leads, new 
recruitment to fill vacancies) 
Policy (recognition of quality as statutory duty of the 
organisation) 
Latest information on evidence-based medicine 
STRUCTURE Clinical Governance Committee 
Performance management for total quality of care 
Protocols and guidelines for clinical care 
Education, training and Continuous Professional 
Development (CPD) strategies for staff 
Clinical audit 
System to integrate all quality activities 
CEO made accountable for quality in healthcare 
Clinical risk management strategies 
Reporting system for errors and adverse incidents 
System to receive patients’ feedback 
Promoting evidence-based medicine 
Leadership development programme 
PROCESS Implementation, monitoring and evaluation of risk 
management 
Job descriptions to include quality as an individual 
responsibility 
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IT training and access for use of latest electronic 
information 
Multi-disciplinary management of clinical care 
Recognition of human resource for quality improvement 
Regular multi-disciplinary clinical audit 
Sharing information, communication and co-ordination 
Systematic clinical supervision to deal with under 
performance 
Training to help health staff cope with their changing role 
in the organisation 
Promoting increased co-ordination among different 
professional groups 
Training to share information with patients, obtain patients’ 
consent and understand the willingness of patients to 
participate in treatment 
Management of patients’ information and safeguarding its 
confidentiality 
Systematic evaluation of clinical errors and adverse 
incidents 
Regular collection of data on clinical care 
Take prompt action on patients’ feedback and complaints 
OUTCOME Continuous quality improvement 
Reduced waiting lists 
Patient satisfaction 
Reduced number of adverse incidents 
Better patient-clinician relationship 
Improved co-ordination between professionals and 
managers 
Increased treatment based on evidence-based medicine 
 
Table 1: Inputs, structures, processes and outcomes associated with clinical 
governance policy implementation 
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3.2. Clinical Governance in LMIC settings 
 
The differences in clinical indicators measured in high-income countries (HICs) 
compared to LMICs has been briefly described above (Azami-Aghdash et al, 2015). 
LMIC healthcare facilities do not have access to the same medical technology, 
information systems and staffing levels as better-resourced HIC facilities and will 
therefore collect and interpret data differently. For example, monitoring septic 
tanks in Iranian hospitals, as a KPI of environmental risk management, will not be 
mirrored in most urban German or Australian hospitals. Social and cultural 
differences, as well as differences in the administration and management systems, 
also influence the selection of indicators. 
 
Similarly, the experience of creating and implementing CG policy will differ 
between the HICs and LMICs. Stakeholders in both settings face similar challenges 
of providing high-quality yet cost-effective health care to an ever-increasing 
population using ever-advancing health technology. But the political, social and 
economic circumstances within which this challenge is faced differ between HICs 
and LMICs. 
 
The majority of published peer-reviewed literature on CG implementation is 
located in HIC settings. For example, the results of the Google Scholar search for 
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publications, from 2014 to 2019, describing CG policy and implementation set in 
LMICs produced one national- or HS-level publication, in Lebanon and Jordan (El-
Jardali and Fadlallah, 2017). The remaining publications focused on programme-
specific CG policies and interventions, e.g. HIV, maternal and child health, and 
mental health, and were set in various locations, including Kenya (1), Pakistan (1), 
Malawi (2), Brazil (2), Ghana (2), Uganda (2), Malaysia (2), Iran (3) and South Africa 
(6). These studies certainly add to the understanding of the practice of CG in LMICs, 
e.g. Bardfield et al, 2015, looking at capacity building in HIV programmes in 
Namibia, as a means to both improve quality and increase resilience in the human 
resource section of that organisation. But the scope for reproducibility and 
inference outside of the programme focus is understandably limited. By 
comparison, in the period 2014 to 2019, over 2000 studies describing CG activities 
in HIC settings are listed on Google Scholar. 
 
Prior to 2014, CG is insinuated in the literature under broader HSS and quality 
improvement activities. Ciccone et al, 2014, and Peters et al, 2009, are two 
examples of reviews conducted on LMIC-located literature looking at broader HSS 
activities and including quality of care or quality improvement as an area of interest. 
Ciccone et al found only 28 appropriate studies, of which only 9 studies show a 
direct link between governance and a positive health outcome and 4 an indirect 
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link. Of these, only 1 (set in Brazil) used “quality of care” as a construct, without the 
use of the term CG but implying a similar meaning. 
 
Peters et al found 98 studies which mentioned quality improvement as a desired 
outcome of more general HSS activities but yet again, no reference to CG 
specifically as a means to action quality improvement. Another example, the 2015 
book edited by Herdt and Olivier de Sardan, contains studies on governance and 
HS strengthening policy and action in Sub-Saharan Africa but CG is presented more 
as a secondary benefit of broader HS, governance or quality improvement 
measures rather than a primary change strategy leading to HSS, stronger 
governance and improved quality. 
 
The book edited by Braithwaite et al, 2015, entitled Healthcare Reform, Quality and 
Safety: Perspectives, Participants, Partnerships and Prospects, provides the most 
concentrated collection of articles specifically on quality of care practices in LMIC 
settings this researcher found. Representatives 30 LMICs from across the world 
were invited to present at the 2013 International Society for Quality in Health Care 
(ISQuA) annual meeting in Scotland. Provided with a template by the editors, these 
researchers created presentations on reforms in their local contexts that fostered 
improvements in quality of care practices. Some key findings include: 
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a. The influence of per capita income on quality policy implementation - when 
countries are still creating core service capacity, due to increase disease 
burden or limited financing, quality reforms fall by the wayside. 
b. Improving access to equitable services that are culturally and lingually 
sensitive are important in countries with multiple cultures and ethnicities. 
These serve to enhance the patient experience even if infrastructure and 
other CG indicators are slower to improve. 
c. The management of health IT and the sharing of patient data determines how 
efficiently and quickly the HS can upgrade and grow. 
d. Mandated hygiene behaviour among clinical staff and continuous training 
thereon are examples of how effective top-down policy implementation and 
the resultant evolution of organisational culture can have a real impact on 
patient outcomes. 
e. Training on leadership and evidence-based clinical guidelines across all 








3.3. Clinical Governance in South Africa 
 
In South Africa, access to health care is enshrined in the constitution. But this does 
not translate into equal and equitable access to health care for all. Gilson and 
McIntyre in a 2007 study showed how despite the presence of policy to the contrary, 
many South Africans did not enjoy health care access, leading to an unequal 
distribution of health services. This can also be called the inverse care law, where 
those with the greatest need are afforded the least access. Challenges to equitable 
service provision in the South African context include a history of inequitable 
resource allocation and unequal health system development, a quadruple burden 
of disease, a chronic shortage of qualified staff, a lack of adequate skills 
development, infrastructure gaps and financing challenges (Chopra et al., 2009; 
Mayosi et al., 2012.) 
 
The South African government recognized these shortcomings and acknowledged 
the role that health system strengthening activities could play in enabling the 
National Department of Health (NDoH) to successfully fulfill its mandate of 
providing all citizens with equitable access to quality health care. It has 
subsequently positioned “an accessible, caring and high-quality health system” at 
the core of its strategy to improving patient care, staff satisfaction, the efficiency and 
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effectiveness of service provision and ultimately trust in the public health system 
(NDoH, 2010, Whittaker et al, 1998). 
 
It established the Office of Health Standards Compliance (OHSC) within the NDoH, 
through the National Health Act (2013). This body is tasked with advising the 
Minister of Health on the norms and standards the NDoH should aspire to and abide 
by, and to ensure compliance with these standards through the licensing, 
accreditation and certification of healthcare establishments, as well as ongoing 
monitoring and evaluation activities (Whittaker et al, 2011). It acts as an ombudsman 
for public complaints relating to the health system and is also responsible for 
developing and operationalizing quality assessments and management systems. 
 
One such system is the National Core Standards (NCS) framework, developed with 
the following purpose: 
 
1. Develop a common definition of quality of health care to guide the public, 
managers and staff 
2. Establish a benchmark against which the process of service delivery and the 
structure of public health facilities can be assessed 




This framework is intended to promote clinical governance activities and asks 
managers to assess service delivery in seven domains, which are areas identified as 
potential risks to quality and safety, described by Connell (2014) to include seven 
domains as listed in table 2 below. Clinical Governance and Leadership and 
Corporate Governance is listed as Domains 2 and 5 respectively, with Quality 
Management and Communication included as sub-domains in the latter. 
 
This can be a rather complex and time-consuming framework to work through for a 
facility manager, so as a form of assistance, the OHSC prioritized problem areas it 
identified during the licensing, accreditation and certification process of health 
facilities and these were subsequently published as the “Fast Track to Quality” plan 
in 2011, borrowing data gathered from the Constitution of SA, the Patient’s Rights 
Charter and the NCS (NDoH, 2011; Whittaker et al, 2011). 
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Table 2: NCS Domains and Sub-Domains (NDoH, 2011) 
 
This plan contains six priority areas, based on the first three domains of the NCS, 
one of which is “keepings patients safe and providing reliable care by reducing 
adverse events resulting from care given, including operations and failures of the 
system and its workers through ignorance, inadequate inputs, systems failure or 
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negligence” (Whittaker et al, 2011). This calls for a change in the organizational 
culture around clinical governance, making it a priority area. 
 
While the policies in place nationally may be relevant and necessary, 
implementation is not uniform across the nine provinces as provincial departments 
of health retain a significant degree of autonomy in determining how to integrate 
national directives into existing provincial, district and local environments.  
 
The WCDoH, for example, has undertaken a series of health system reforms to 
improve service delivery to citizens since 1994, published in a series of periodic 
strategic policy documents, the latest of which is the Healthcare 2030 document. 
These policy documents describe how the WCDoH plans to localize national health 
directives while addressing local priorities at the same time, given the resources 
available to it. For example, in the case of leadership and governance, the WCDoH 
committed in Healthcare 2030 to creating enabling conditions that allow for good 
governance to manifest, including the necessary policy development (e.g. District 
Health Council Act and Health Facility Boards Act), institutional arrangements, 
authority- and decision-making arrangements (WCDoH, 2014). 
 
For this section on leadership and governance, it has borrowed from two 
frameworks to frame its perspective on governance, viz. the UNDP Principles of 
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Good Governance framework, discussed above, and the Competing Values 
framework. It uses the former to frame the discussion on the role of leadership and 
governance in improving the quality of care and the latter to speak to the changes 
required in organisational culture to enable these initiatives. 
 
The Competing Values Framework, visualized in diagram 1 below, contains four 
contrasting domains of organizational effectiveness, where the inherent value of 
people within an organization is contrasted against their value based on the results 
they achieve, and the ability of an organization to adapt to change and innovate 
new processes contrasts with the need for stability and continuity through the use 
of rules and guidelines (WCDoH, 2014). It is assumed that prevalent organisational 
culture is a result of a mix of competing values from each cultural type but that one 
of these types dominates each team/unit/organisation (Prenestini et al., 2015). 
 
 
Diagram 1: Competing Values Framework (WCDoH, 2014) 
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It has been used extensively to study the intersection of organisational culture and 
clinical governance, especially the relationships between actors and the impact of 
culture on a variety of organisational issues including human resource management 
and change management. (Goodman et al, 2001; Prenestini et al, 2015; Viitanen et 
al, 2015).  
 
Ultimately, the WCDoH used the Competing Values framework to create its own 
clinical governance framework where clinical governance is defined as “a 
framework through which organizations are accountable for continuously 
improving the quality of their services and safeguarding high standards, through 
creating an environment in which excellence in clinical care can flourish” (WCDoH, 
2014). 
 
The components of this framework include: 
 
(i) Clinical accountability with clear clinical and professional standards 
against which performance of health workers is measured 
(ii) Effective teamwork with interdisciplinary co-operation 
(iii) Well-defined, comprehensive service packages for various levels of care 
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(iv) The use of evidenced-based clinical interventions to achieve clinical 
effectiveness 
(v) Continuous monitoring and evaluation of individual health outcomes, 
adverse incidents and adherence to clinical standards and guidelines so 
as to effectively manage risk 
(vi) Continuous professional development 
 
This framework places the responsibility on both clinical and organisational 
leadership and management and emphasizes the role management culture has on 
this process.  
 
However, the process of translating policies and frameworks into practice involves 
more than writing policies and frameworks and sending them down the 
bureaucratic pipeline. It is influenced by the actors involved, the content of the 
policy, the context within which the policy is being introduced (incl. situational, 
structural, cultural and international) and the process used to both develop, 
implement and evaluate the policy (Buse et al, 2012). And it requires monitoring 
and evaluation to assess if the service experienced by consumers is the same as the 
service described by policy makers. While one can evaluate the more tangible 
outcomes of policies, such as those directed at clinical governance initiatives, by 
assessing for concrete changes in the level or quality of service delivery, it is equally 
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valuable to evaluate how implementation took place to observe for factors that 
facilitate or hinder policy implementation both in general and with regards to 
specific policies. 
 
This will be invaluable as the NDoH gears up to implement NHI. In the new  bill, 
published in July 2019, it builds on existing CG-related structures like the OHSC by 
(1) introducing the  Benefits Advisory Committee (BAC), a wide-reaching committee 
that will be responsible for determining the mix of facilities, providers and services 
in different communities using health and demographic data, and (2) further 
decentralizing of the health system, taking decision-making and cost centers down 
to district level, coordinated centrally by the District Health Management Office 
which will be located in Pretoria. A concern is that the NHI Fund puts itself forward, 
in conjunction with the District Health Management Office, as the guardian and 
evaluator of clinical governance nationally and that it will use this information to 




Clinical governance offers stakeholders invested in creating a more equitable HS 
for all a tested and practical means to achieve their goal. It crosses discipline and 
political lines and unites stakeholders under the goal of doing better by patients. It 
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is this multidisciplinary and multifaceted approach that allows it to adapt to a variety 
of circumstances and environmental factors yet have implementation strategies 
remain focused on improving the user experience of the health system. Gray, 2005, 
defined it as a comprehensive means to effectively manage resource use, the 
patient experience, clinical effectiveness, risk and strategic growth while encourage 
ongoing engagement with the above among stakeholders. It is truly a versatile tool 
when wielded skillfully. 
 
This skill is one that borrows from knowledge and experience in both academic and 
field-based settings and allows the dissemination of knowledge and tools between 
HICs and LMICs. While each has its own set of unique demands and risks, there is 
opportunity for collaboration and mutual learning across the development divide. 
In order for practitioners, policy makers, administrators and other interested 
stakeholders to hone their CG skill set, more needs to be done to increase 
awareness of the practical application of CG models and theory and to share this 
case history between geographical and economic divides. As countries across the 
world grapple with the cost-vs-quality challenge, CG will prove invaluable in 





Part C: Journal-Ready Article 
 
Journal targeted: BMC Health Services Research 
 
Title of the article: An Exploration of Clinical Governance Policy and Practice in an 
LMIC setting 
 






The tension between the increasing cost of healthcare provision and the need to 
provide a quality level of care to a rising number of people is a global phenomenon. 
A focus on one over the other could result in a rise in adverse patient outcomes, or 
a health system too costly to be sustainable. Clinical governance is an approach 
policymakers can use to walk the middle line of creating a healthcare service that 
meets quality of care standards in a cost-effective manner, as has been done in 
Australia, Burundi, Egypt, Spain, UK and Yemen (Goyet et al, 2019; Abd El Fatah et 
al, 2019, Mannion et al, 2015; Aguilar Martin et al, 2019). 
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This study examines the practice of clinical governance in one LMIC setting that has 
been able to successfully do this balancing walk for 20 years. Understanding how 
this was done in the Western Cape province of South Africa helps inform how 
clinical governance can be used to continue adding value as the national health 
system moves towards universal healthcare. In addition, this South African 
experience adds to the still small pool of relevant experience from low- and middle-




A mixed methods qualitative design was used for data collection and involved  three 
phases: (1) a document review of all policies in the province to identify clinical 
governance structures; (2) observation of these structures in action, comparing 
lived to written experience of clinical governance; and (3) interviews with key 
stakeholders in the province to get their perspectives on past, present and future 
forms of clinical governance. The Donabedian model was used to frame analysis 








Beyond a comprehensive policy framework, collaborative structures and 
consultative leadership styles facilitated strengthened clinical governance in the 
Western Cape. For example, although corporate-governance-inspired structures, 
such as clinical audits and M&E events, may become punitive and corrosive, the 
potential negative impact on clinical governance outcomes and organisational 
culture was tempered by healthy communication and supportive relationships 
between colleagues. Family physicians have become the champions of clinical 
governance in a decentralized health system and when supported in this by policy 




Clinical governance is an effective strategy or tool LMICs can use to ensure quality 
of care is maintained or improved upon, even in resource-challenged settings. But 
while some structures, processes and outcomes may be borrowed from other LMIC 
or HIC settings, these need to be contextualized to local conditions. Appropriate 
clinical governance champions need to be identified and given the appropriate 
mandate. Human relationships are key to the successful implementation of 
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This study began as part of a larger research project called WholeSystSA, a broad 
study to evaluate 20 years of health system transformation in the Western Cape 
province of South Africa, from democracy (1994) until 2016, when WholeSystSA 
began. WholeSystSA was conducted by a team from the University of Cape Town, 
the University of the Western Cape and the Western Cape Department of Health, 
who used interviews, workshops and document reviews to understand what factors 
enabled the heath system in this province to fare better than other provinces. 
Examples of these successes include a higher “TB-cure rate (new smear-positive)” 
of 80% compared to a national average of 74% (Gilson et al, 2017) and an “Antenatal 
1st visit before 20 weeks rate” of 67.7% compared to a national average of 61.2% in 
2015/2016 (Nsibande & Ngandu, 2017). 
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During the WholeSystSA study, clinical governance was brought up on multiple 
occasions as an influential factor to the success of the Western Cape health system. 
Subsequently, this researcher was tasked with exploring the history of clinical 
governance in the province. 
 
By exploring past and present clinical governance initiatives, the hope is that the 
use of this tool for future health system strengthening and quality improvement will 
become easier and more accessible. 
 
Clinical governance has a become a globally recognized strategy, involving peer-
review, to achieve improved quality of care (Campbell et al, 2001). It is also a central 
tenet in the South African discourse around universal healthcare and has a central 
role in current proposals for National Health Insurance (NDoH, 2019). The proposals 
suggest that in future providers will be contracted to the NHI fund only if they are 
certified as of adequate quality. However, there is widespread public concern, be it 
warranted or not, that the quality of public service is sub-optimal and could 
compromise their health outcomes. 
 
The term clinical governance was first coined in the late 1980s in the UK to describe 
a solution to quality issues being faced by the UK health system at the time. An early 
definition, is that by Scally and Donaldson, 1998, who describe it as “a framework 
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through which NHS organisations are accountable for continually improving the 
quality of their services and safeguarding high standards of care by creating an 
environment in which excellence in clinical care will flourish.” 
 
Activities included under the term include (1) Processes that monitor, improve 
where quality is found lacking and hold accountable stakeholders responsible for 
the above, (2) the creation of an organisational culture that supports safe, high-
quality, patient-centred service provision, (3) broad stakeholder engagement, such 
a politicians, regulators, managers, patients and the broader public, in creating 
positive change in the health status of a community, and (4) increased 
accountability and responsibility for monitoring and oversight of clinical activities 
by all stakeholders, particularly management  (Brennan and Flyn, 2013; Gunst et al, 
2016). 
 
This aim of this study is threefold: 
 
1. To describe the structure of clinical governance in the Western Cape, in 
terms of history and evolution, 
2. To understand the process of how these structures are operationalized and 
governed, 




4.1. Study Design 
 
The design employs a mixed methods qualitative approach, structured into three 
iterative and concomitant phases, continuing in cycle until information saturation 
occurred or time ran out. In each phase a different set of data were collected. 
 
Phase 1 - Scoping Review 
A scoping review was conducted using publicly available policy documents and 
published literature. The purpose was to identify clinical governance structures 
mandated by or defined in the policy and to understand the role these played in 
clinical governance in the province. These included Western Cape Department of 
Health (WCDoH) 10-year strategy plans, the provincial annual performance plans 
and National Department of Health policy documents. 
 
Phase 2 - Direct Observation 
Direct observation of accessible clinical governance structures currently in use. 
Three GSA committee meetings were attended in November 2016, in the Cape 
Metro, Eden and Winelands districts, and one Family Physician Forum was 
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attended. The aim was to observe clinical governance in action and compare this to 
what is described in policy documentation. 
 
Phase 3 - Semi-Structured Interviews 
Eleven semi-structured interviews were conducted with senior clinicians and/or 
managers in the Western Cape Department of Health between September and 
December 2016, who were, at the time, engaged with clinical governance initiatives 
in the public sector. Although it had been intended to conduct 20 interviews, 
several were unable to create space in their schedules and some did not respond 
to the invitation. Participants were recruited either by word of mouth or through the 
Phase 2 observations. 
 
4.2. Study Setting 
 
The study was set in the public health system of the Western Cape province of South 
Africa. This province was chosen because despite sharing similar financial 
constraints and national policy directives with other provinces in the country, its 
health system has a reputation of performing more strongly than other provinces, 
as considered further in then larger study to which this CG work was linked (Gilson 
et al, 2016). 
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4.3. Data Collection and Analysis Methods 
 
Phase 1 required the researcher to do a substantial review of all policy documents 
published by the Western Cape Department of Health between 1994 and 2016, that 
could potentially contain reference to clinical governance (or quality improvement) 
activities or structures. A search through each policy was initially made using key 
words/phrases including “clinical governance” and “quality control” but this proved 
inaccurate as several clinical governance structures were described without the use 
of these key phrases. Thereafter all policies were reviewed in full and analyzed using 
the Donabedian model. 
 
WholeSystSA also conducted a policy review and this researcher looked to their 
study for broader policy guides and contextualizing factors. 
 
The observations of Phase 2 were not allowed to be recorded due to the sensitive 
nature of some of the topics of discussion. Therefore, observer notes and reflexivity 
journal entries served as a data source. These were analyzed using the Donabedian 
model and compared to the findings of Phase 1. 
 
The interviews of Phase 3 were first transcribed and then thematically analyzed 
using the Donabedian model and compared to the findings of Phases 1 and 2.  
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This study uses the Donabedian model as a framework through which to analyse its 
findings. Three dimensions of care are described, viz.: 
 
1. Structure - describing the organisational structure and legal and policy 
frameworks that facilitate an intervention 
2. Process - describes the way in which an intervention is conducted, the 
relationships and flow of information between levels within an organisation 
and between organisations and stakeholders. 
3. Outcomes - describes the impact of an intervention and the indicators used 
to monitor and evaluate it. 
 
4.4. Ethics and Rigor 
 
Ethics approval for this study was obtained from the Ethics Committee at the 
University of Cape Town in September 2016, reference number 630/2016. Written 
informed consent was obtained from each interviewee and each participant of any 






The principles of rigor applied in the study were: 
 
1. Minimising observer bias through validating findings from the phase 2 
observation and data analysis processes with the interviewees in phase 3. 
2. During phase 3, interviews were primarily conducted in English as managers 
are required to have a working knowledge of the language to perform their 
duties. Although the interviewees were offered the opportunity to respond 
in a language of their choice, all were comfortable speaking English. 
3. Data sets were triangulated in terms of both data source and data analysis. 
Findings from the document review framed and informed the subsequent 
qualitative observation and interview processes. The findings of the 
qualitative interview phase were used to interpret and add context to the 
results of the document review and observation phases. Theoretical 











5.1. The Structure of Clinical Governance  
 
The first objective, of three, of this study is to define the structure of clinical 
governance in the Western Cape and how it has changed since 1994, the onset of 
democracy in South Africa. From the Donabedian model, this describes the 
organisational structure and legal and policy frameworks introduced that relate to 
clinical governance within the Western Cape province. 
 
1990 - 1994: Pre-Democracy 
 
To give context to the findings of this study, the researcher began by exploring 
health system interventions pre-1994 but en route to the new political dispensation. 
Pre-democratic SA was a fragmented society in many ways. With respect to the 
health system, health departments existed for each of the four government-defined 
racial groups (black, mixed race, Indian and white), distributed semi-nationally 
(some groups were not allowed in some provinces) in the country, and for each of 
the 10 Bantustans (ethnic homelands), created to locate communities of black 
people outside the borders of SA, removed from their economic and political 
agency. Financing of these 14 departments of health was neither equal nor 
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equitable, with everything from regulatory bodies to staffing levels, access to drugs 
and technology to standards of care, differed between them all (Baker, 2010; 
Maphumulo & Bhengu, 2019). 
 
The task to desegregate the disparate health systems into one syncretic HS began 
in 1990, soon after President FW de Klerk took office, and fell to the first female 
cabinet minister in SA history, Dr Rina Venter, a PhD social worker, in her position 
as Minister of National Health and Population Density. The HS was a hospital-centric 
one and the 240 hospitals in existence at that point were opened to all races with 
Dr Venter announcing that service delivery would be based on the principles of 
equality and accessibility (Allen, 1991; Los Angeles Times, 1990). 
 
While no policies or publications from peri-democratic SA (1990-1994) could be 
sourced that spoke to the form clinical governance or quality improvement 
initiatives took during her time in office, there was some indication that Dr Venter 
favored a multidisciplinary comprehensive approach when reading commentaries 
on the HIV/AIDS plan devised by her department (Meyer, 2004). 
 
When the political borders went down, population movement across the country 
saw three key system-shaping developments occur, that also shaped the health 
system South Africa currently operates with: 
 89 
1. Rapid urbanization - people followed the money and moved from low-
resource settings in the previous Bantustans to higher-resourced settings in 
urban centers around Cape Town, Johannesburg-Pretoria, Durban and other 
larger cities.  The health systems in these cities were not built to manage the 
influx of people and quickly became overwhelmed. Health funding and 
resources did (could) not move to match population movement fast or 
adequately enough. 
2. Increasing privatization - people from previously or more-privileged 
population groups, fearful of not being able to access quality healthcare on 
demand, sought an alternative to the public health system that previously 
was able to meet their needs (Young, 2016). This allowed private healthcare 
funders and providers to mushroom. With bigger pools of money to spend, 
the private sector attracted more specialists, health technology and 
healthcare infrastructure for the population served compared to public 
sector and has resulted in disparate per capita healthcare spends - $150 per 
capita in the public sector and $1,500 in the private sector (Benatar, 2013). 
3. The dawn of the quadruple burden of disease - (i) HIV/AIDS and TB; (ii) 
Maternal, Newborn and Child Health; (iii) Non-Communicable Diseases; and 
(iv) Violence and Injury. In addition to facing the challenge of creating a new 
health system with equitable distribution of human resources, infrastructure, 
technology, etc. across a larger population group, the new National 
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Department of Health (NDoH) would have to grapple with the unique 
challenges associated with each of the above-mentioned disease burdens. 
 
1994 - 2002: Provincial Health Plan 1995 
 
Post-democracy, Dr Venter was succeeded by Dr Nkosazana Dlamini-Zuma (1994-
1999), a medical doctor-political activist, who steered the new National Department 
of Health through further desegregation and reconfiguration into one functional 
health system. This transition period was guided by a series of documents that 
influenced and guided subsequent policy and system engineering, including the 
National Health Plan for South Africa (1994), the Western Cape Provincial Health 
Plan (1995), the Constitution of the Republic of South Africa (1996), and the White 
Paper for the transformation of the Health System in South Africa (1997). 
 
During this period, the focus of health system development shifted to the 
development of a decentralized, primary healthcare-focused HS that was organized 
into national-, provincial-, local- and district-level structures (NDoH, 1994). In the 
Western Cape, this was exemplified by hospital beds being closed in some areas 
while Community Health Centers (CHCs) were extended or upgraded in others. 
Budgetary constraints reduced the number of doctors, nurses and pharmacists in 
the health system and clinical nurse practitioner, community health worker and 
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pharmacy assistant roles were created to more appropriately fill in the needs of a 
decentralized health system. And to further the decentralization objective, 
comprehensive service provision as close to where the patient lives was 
encouraged, while ensuring integration into broader district, regional, provincial 
and national structures. 
 
The term clinical governance had not yet been coined but some reference to what 
would come to be included under the umbrella of clinical governance does get 
inferred in the policies listed above. 
 
The Western Cape’s Provincial Health Plan, 1995, was quite focused on laying out 
the who, what and where of the new provincial health system and did not speak 
explicitly to the how beyond points on coordinated service provision, community 
participation in decision-making processes and ongoing education, training and 
evaluation of personnel in response to future needs analyses. 
 
The National Health Plan for South Africa, 1994, mentions “…maintenance of good 
quality of care,” as a responsibility for the new health authority at a level 
decentralized to the lowest level possible within the local-district-provincial-national 
structure. Licensing was to be explored as a mechanism to encourage high quality 
of care and facilities would be supported to improve and strengthen their ability to 
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deliver quality health care to citizens. No mention is made on how these measures 
would be carried out, who would be responsible and the origin of funding. 
 
Overall, the policies of this period are focused on setting up the nuts and bolts 
physical infrastructure of an equitable heath system, filling these with appropriately 
trained and skilled staff, technology and drugs, and financing all these activities. 
How these parts work together and with what level of efficiency comes later. 
 
No interviewees could recollect further CG-specific structures or activities from this 
period, with one saying it was assumedly the way things were done: “…provide the 
best quality of service you could, given the circumstances you were surrounded by 
at that time.” (i5) 
 
2003 - 2013: HealthCare 2010 and the Comprehensive Service Plan 
 
HealthCare 2010 and the Comprehensive Service Plan (CSP) were the successors 
to the 1995 Provincial Health Plan as the guiding policy documents for broader 
health system design and engineering in the Western Cape. Desegregation and, to 
some degree, reconstruction of an integrated service, accessible to all citizens of 
the province, had taken place. 
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The gaps in service delivery and the infrastructure network had become apparent 
once the dust had settled and a new plan of action was needed to guide the HS 
towards ensuring equal access to quality health care for all citizens. HealthCare 
2010 listed two challenges it intended to meet: (1) improve the quality of service 
delivery and (2) reduce the expenditure to within budget. To do so it put forward a 
series of far reaching plans, including: 
 
1. Service delivery plan - defining and quantifying the services rendered, based 
on community needs analysis, and in a decentralized and integrated way. 
2. Infrastructure Plan - increase the value of existing assets and provide for new 
assets (assets being buildings, equipment and maintenance thereof) along 
the needs identified in the Service Delivery Plan. 
3. Human resource plan - appropriate staffing allocated to appropriate facilities 
to meet the requirements of Service Delivery Plan. This required a revision of 
existing staff establishments, which until then had simply taken the form of 
amalgamating staff from previous pre-apartheid structures into one new 
structure without a needs analysis being done. The challenge to recruit, train 
or retrain and retain clinical staff, particularly in the rural and underserved 
areas, was a significant and growing one as many qualified and experienced 
staff left for more lucrative local and international markets. 
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4. Financial implementation plan - budgets linked to measurable and time 
bound objectives to make service delivery affordable and sustainable. 
 
According to one interviewee, HealthCare 2010 “enabled the founding of clinical 
governance in the province. It was a road map…got people to do think and do 
difficult things…be accountable for resources they were responsible for.” (i2) 
 
For the majority of interviewees, this is when they recall clinical governance and a 
specific focus on quality improvement, entering the policy and implementation 
discourse in the province. One described “consultants being flown in from the UK in 
the early 2000s to host workshops” on this “strange, new topic” where hundreds of 
clinicians and service providers were introduced to the concept of clinical 
governance. (i1) 
 
At a systems level, quality of care or clinical governance was spoken to in the 
provincial Annual Report (on financial statements, performance indicators and 
departmental activities) and the provincial Annual Performance Plans. For example, 
the Annual Performance Plan 2005/2006 discusses the establishment of a Quality 
Assurance Unit to “monitor quality of care via monitoring complaints and 
compliments, morbidity and mortality meetings, client satisfaction surveys and 
evaluation of safety and security risks to patients and staff.” This time period is 
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marked by “brain drain” - the movement of quality health care professionals out of 
the public sector. Reports and Performance Plans for several years report this as a 
major factor impeding quality of care improvement strategies. 
 
There is also mention of a NDoH 5-year priority plan, one being to “continue 
towards human dignity by improving quality of care.” The plan recommends (1) 
strengthening community participation at all levels, (2) improving clinical 
management of care at all levels of the health care delivery system and (3) 
strengthening the hospital accreditation system in line with national norms and 
standards. The province responded with a number of initiatives, including 
developing a provincial policy on Quality Assurance - which one interviewee 
pointed out was, in his opinion, directed more to managing the patient experience 
via complaint management and patient surveys than improving clinical governance. 
 
The main practitioner-directed intervention was the introduction of clinical 
Monitoring and Evaluation (M&E) meetings, also known as Morbidity and Mortality 
(M&M) meetings, at district level with a designated official responsible for 
coordinating quality management in that facility or district. One interviewee spoke 
of M&E meetings as being either useful or quite damaging to clinician moral, mental 
health and ultimately retention, depending on whether the M&E meetings were 
conducted as spaces errors were highlighted punitively or as opportunities to 
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contextualize the incident, self-reflect and learn. Her example was of a doctor 
having seen 50-60 patients on a particular workday, going on call that evening 
already fatigued and making an error that caused harm to a patient. They were 
either only judged on the error or supported to learn from and improve on the 
experience. (i4) 
 
This interviewee further reported that chairs of M&E meetings aren’t routinely 
trained on how to turn these meetings from demoralizing “blame games” to 
reflection and learning opportunities, and that it only her experience as a family 
physician and further training on clinical coaching from the University of 
Stellenbosch Department of Family Medicine and the Royal College of GPs that 
gave her this skill set. (i4) 
 
Annual Performance Plan 2006/2007 is the first mention of a new strategy to 
introduce family medicine as a speciality in CHCs to “provide clinical governance to 
PHC particularly for chronic disease Management (sic).” The relationship between 
family medicine practitioners or family physicians (FPs) and clinical governance (CG) 
in the public sector will continue to grow, as discussed below. 
 
Annual Performance Plan 2006/2007 is also the first to mention the appointment of 
clinical co-ordinators, one for each major discipline, such as paediatrics or 
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anaesthetics, whose spend 50% of their time in this coordinating role. This includes 
working on (1) quality and safety of care, (2) uniform clinical guidelines, (3) seamless 
patient care management, and (4) ensuring the right patient gets managed at the 
right level and with the right skills and at the right costs. These were specialists from 
tertiary level who moved through the various levels of the HS and across the whole 
province. 
 
One interviewee viewed being appointed as a “co-ordinating clinician” as his first 
step into the CG arena. There was no written CG mandate, but it was understood to 
be part of his role. But he also described the role as “having no teeth” - “you were 
on the ground, with eyes and ears throughout the province, and short reporting 
lines to top management, but without any real power to do something about 
problems you saw” (i1). Co-ordinating clinicians were dissolved 2-2.5 years later 
because if this inability to effect change. 
 
This plan also describes the need to (1) develop evidence-based treatment 
protocols that are accepted by all stakeholders, (2) have clinician-developed 
management tools to monitor quality of care and (3) create a multidisciplinary 
quality assurance team. These fit neatly into the elements of the Structure dimension 
of the Donabedian model as described by Vanu Som, 2004, and described above. 
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Annual Performance Plan 2008/2009 reiterates the role of FPs responsible for CG 
at district level and tasks them with instituting annual clinical audits at every facility, 
implementing a PHC information system (PHCIS) to gather data to support said 
audits, and to improve quality of care in the chronic disease, HIV/AIDS and other 
disease management systems. It lists as key performance indicators (KPIs) the 
number of FP registrars employed in the district health system and the number of 
district hospitals with FPs, indicating a desire to ensure a steady growth in the 
number of trainee and qualified and experienced FPs available to the HS. 
 
Annual Performance Plan 2009/2010 introduced a new organisational structure to 
the HS in terms of clinical service delivery - PHC, followed by Level 1, 2 and 3 - each 
with a different level of clinical services. From an infrastructure perspective, PHC 
would be a clinic in a local community, staffed mostly by clinical nurse practitioners 
(CNPs) and occasionally a medical officer (MO) or specialist FP. Level 1 would be 
district level facility, with a mix of CNPs, MOs and specialist FPs and able to offer a 
more comprehensive set of services. 
 
Level 2 and 3 would be central and tertiary/training hospitals, would see 
increasingly complex clinical cases and had a mix of MOs, registrars and specialists 
organized into three clusters: Cluster 1 (emergency medicine, internal medicine, 
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psychiatry), Cluster 2 (surgery, orthopaedics and anaesthetics) and Cluster 3 
(obstetrics and gynaecology, paediatrics and neonatology). 
 
As one moves up from PHC to Level 3, the number of patients and facilities decrease 
but the cost as well as the complexity of care provided increase. The goal is to 
service patient needs at lower levels as much as possible and mirrors the goal of 
HealthCare2010 to decentralize service provision. 
 
At PHC and Level 1, FPs continue to lead CG initiatives. But in 2 and level 3 facilities 
don’t have FPs. The Annual Performance Plan 2009/2010 speaks of the 
appointment of level 2 clinical heads for each speciality who will share the CG 
strengthening role with FPs in their respective facilities and districts/areas. Co-
ordinating clinicians were described as functioning across all levels of care and 
playing a unifying role between FP and Level 2 head. 
 
Annual Performance Plan 2010/2011 builds on the previous by requiring junior 
doctors to also receive training and support to improve quality of care and makes 
this the responsibility of FPs and Family Medicine registrars. 
 
Annual Performance Plan 2011/2012 introduces provincial co-ordinating structures 
in each discipline, dedicated to “developing uniform clinical guidelines, system 
 100 
strengthening strategies and skills development at less specialised levels of care.” 
These are also known as the Provincial Clinical Governance Committees (PCGCs) 
and are comprised of all the specialists in a particular field from throughout the 
province, along with some representation from WCDoH management and a family 
physician, whose task it was to communicate the findings from the PCGCs to Level 
1 and PHC staff, via other FPs in the province, and through them to the rest of the 
healthcare team. Specialists would disseminate findings to their respective Level 2 
and 3 departments (i4, I5, I6, i9). 
 
They meet every three months and are an opportunity for colleagues in a field to 
share experiences, foster a common perspective on challenges and share problem-
solving solutions. Despite the wording of the policy paper, very little clinical 
guideline development took place, with the norm being more the localization of 
guidelines sent down from national level. This was mentioned by several 
interviewees as a disappointing shortcoming of the PCGCs - “all talk, no teeth” as 
one interviewee put it (i1). 
 
Another shortcoming mentioned during interviews was that unless the participating 
physicians chose to, non-physician service providers were not included in 
discussions or had outcomes shared with them. For example, in the anaesthetic 
PCGC discussing theatre protocols, theatre nurses and theatre management were 
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not involved and as such no decisions or implementation strategies could actually 
be settled on. This lack of a multidisciplinary approach goes against a key CG 
approach to ensure all members involved in a particular service share the same 
degree of training, awareness and attention to detail that creates good quality of 
care. 
 
Family physicians and family medicine registrars are once again described as key 
CG champions and CG policy in the province is aligned with national directives on 
quality assurance coming from the Office of Standards Compliance and the 
National Core Standards, discussed below. 
 
This plan also describes a new organisational structure in the province, 
Geographical Service Areas (GSAs), initiated in 2010 and still active at the time of 
this research in 2016. These were functional committees that did not impinge on 
other statutory or administrative/managerial structures. They were multi-
disciplinary in nature and demarcated along district/geographic lines: 
 
1. Two urban GSAs in the Cape Metro District: 
a. Metro West 
i. Facility: New Somerset Hospital 
ii. Area: Central and Southern Cape Town 
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b. Metro East 
i. Facility: Tygerberg Level 2 Hospital 
ii. Area: Northern and Eastern Cape Town 
2. Three rural GSAs from the remaining five districts of the Western Cape: 
a. Worcester 
i. Facility: Worcester Provincial Hospital 
ii. Districts: Cape Winelands and Overberg - combined for 
operational and logistics reasons. 
b. Paarl 
i. Facility: Paarl Provincial Hospital 
ii. District: West Coast - Paarl/Drakenstein falls geographically into 
the Cape Winelands district and therefor the Worcester GSA 
but the West Coast refers patient to Paarl Hospital and therefore 
their GSA was located there. 
c. George 
i. Facility: George Provincial Hospital 
ii. Districts: Central Karoo and Eden - geographically large but 
sparsely populated. 
 
The intention was “to strengthen service coordination and communication between 
institutions and across levels of care” within a GSA region. Representatives from all 
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facilities and all disciplines present within a GSA region were included. They were 
subdivided into working groups called Service Co-ordinating Working Groups 
(SCWGs), based on 6 domains - (1) women’s health, (2) child health, (3) chronic 
disease, (4) mental health, (5) emergency services and (6) surgery, orthopaedics 
and anaesthetics. Each SCWG would discuss challenges faced in their region and 
domain, workshop solutions and implement changes pertinent to them as all the 
required decision makers (clinicians, policy makers, managers) were present. 
 
The GSA would meet monthly at the Level 2 facility, each month chaired by a 
different SCWG who would present their recent challenges, solutions and insights 
to the broader GSA. While a paediatric nurse may not necessarily be interested in 
the same issues as an orthopaedic surgeon, this shared forum served to keep 
everyone in the HS informed of challenges and changes in the whole HS and 
allowed the process of collaboration, problem solving, innovation and M&E to be 
shared between more- and less-adept SCWGs.  
 
GSAs were the main forum listed by interviewees for cross-disciplinary engagement 
on key CG-related topics and had the most positive feedback in terms of efficacy in 
improving CG and quality of care in the province. 
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From interviewee feedback and observing both urban and rural GSA meetings, this 
researcher concluded that this was true in the rural GSAs, which continued 
unchanged in structure and process today as when first begun in 2010. But the 
urban GSA had changed significantly from the 2010 beginning. 
 
The two urban GSAs were combined into one Metro GSA in 2014 and according to 
one interviewee, this resulted in too many people with too diverse a set of 
conditions in which to work (i7). This respondent further stated that the disease 
burdens, sociopolitical and cultural norms, and infrastructure challenges in Metro 
East and West are too diverse for colleagues from both sides of the Metro district 
to share similar solutions to common problems. Beyond acting as a networking 
opportunity, this had led to decreased enthusiasm for GSA participation and lower 
expectations for real action-driven problem solving. No reasons for why Metro East 
and Metro West were combined could be elicited from the policy documents or 
from the interviews. However, some old SCWG formations had continued to 
function without amalgamating West and East, e.g. the Surgery- Anaesthetic SCWG 
of Metro West, who continue to function according to original efficiencies. (i1) 
 
Annual Performance Plan 2012/2013 sees the debut of National Health Insurance 
(NHI) and Universal Healthcare (UH) into the policy space at provincial level. The 
plan lists, (1) Increasing the family physician head count in the district health system 
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and, (2) strengthening the collaboration between family physicians and specialists 
in the GSA structure through the appointment of Heads of General Specialist 
Services to each GSA, as two key CG-supporting improvements taking place during 
this period. In addition to supporting CG initiatives, these new Heads will also be 
responsible for skills development and monitoring referral pathways - similar to the 
task set of the Co-ordinating Physicians of the early 2000s. The GSAs had also 
become a key vehicle through which CG strengthening and clinical leadership 
development activities organized by provincial management are to take place. 
 
2013 - 2016: HealthCare 2030 
 
HealthCare 2030 is the successor to HealthCare 2010 as the overarching strategic 
plan for the province and sees a refinement of the decentralized, people-centered 
service delivery focus of the previous policy. However, the focus now moves from a 
curative paradigm to a preventative one, where positive health and wellness levels 
in communities are actively nurtured. It is more value-driven with values incl. caring, 
competence, accountability, innovation, responsiveness and respect (C2AIR2) being 
positioned as equally important as historic KPIs (Gilson et al, 2017). 
 
Quality of care is a central tenet, following in the footsteps of the NDoH. It invokes 
the frameworks and mechanisms of the National Health Act, the National Core 
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Standards and the Office of Health Standards Compliance to support this 
positioning of quality of care. A policy framework for CG was developed “through 
which organizations are accountable for continuously improving the quality of their 
services and safeguarding high standards, through creating an environment in which 
excellence in clinical care can flourish” leaning on the definition of CG put forward 
by Scally and Donaldson, 1998. 
 
The Policy Framework for Clinical Governance, 2011 positioned patient satisfaction 
as a result of the technical quality of the interaction between the client and provider, 
and that this technical quality is improved upon or influenced by clinical governance 
(Western Cape Department of Health, 2011). The expectations and perceptions of 
the client of their entire experience of engagement with the HS, extending beyond 
the clinical consultation, are also included as influential factors. As are factors 
leading to low provider performance, e.g. burn-out, depression, etc. “Caring for the 
carers” becomes as important as caring for the patients. 
 
Part of the dissemination process of the framework included various workshops, 
where cross-discipline coordination of care and communication were described as 
important to the success of CG implementation. GSAs and PCGCs were described 
as structures that could serve this purpose, thus their continued presence in 
successive performance plans and HS strategic documents. 
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FPs were also seen as holding the primary responsibility for developing a site-
specific strategy and implementation plan for CG at district level (Connell, 2014). 
They were given the lead of guiding the district multidisciplinary clinical team in 
engaging with CG but not being seen themselves as the sole executor of CG. To 
support and develop the FP’s CG-function, Family Physician Forums (FPF) were 
identified as platforms for sharing best practices and peer learning while remaining 
accountable to management. (Gunst, 2016). These forums had been in place prior 
to the launch of policy framework and were an informal means for FPs to connect 
and share. After being formalized through this framework implementation process, 
they created a “terms of reference” for meetings and reporting line to the District 
Management Committee (DMC). 
 
One interviewee described this formalization process as positive: “felt like we’ve got 
more of a voice now as we’re expected to feedback to the DMC, and they consult us 
on policies and strategies that affect how we work.” (i5) This interviewee goes on to 
elaborate by saying that the link between FPF and DMC allowed urban FPs access 
to management structures and an opportunity to create change, while rural FPFs 
didn’t enjoy a similar relationship because the DMC structure did not exist in the 
same way there. 
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A rural FP interviewee responded by clarifying that their FPF enjoyed simpler and 
easier access to management because there were fewer management structures in 
the rural setting. One director, 5 deputy directors (finance, HR, pharmacy, 
professional support systems {aka hospitals} and comprehensive care {primary care 
and programmes}) and 1 FP make up the District Management Team where 
decisions are made. (i4, i6) 
 
The National Core Standards, 2011, referred to above are a national policy that 
describe seven domains that provide the minimum legislated standards the HS 
must meet in order to deliver quality health services that achieve the desired health 
outcomes. These include (1) Patient rights, (2) Patient Safety, Clinical Governance 
and Care, (3) Clinical Support Services, (4) Public Health, (5) Leadership and 
Corporate Governance, (6) Operational Management, and (7) Facilities and 
Infrastructure. How these standards are converted into policy and implemented is 
left to the provincial health authorities, e.g. HealthCare 2030 for the WCDoH. 
(National Department of Health, 2011). 
 
Annual Performance Plan 2012/2013, Annual Performance Plan 2014/2015 and 
Annual Performance Plan 2015/2016 build on the previous performance plans, 
reinforcing the importance of CG to HSS and the role of the GSA and PCGC in 
implementing CG in the province. 
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Annual Performance Plan 2013/2014 references national NHI policy and from a 
more aligned perspective. A key component of the NHI system is a stronger district 
health model but how that would take form was uncertain at that stage. Ten pilot 
sites were set up nationally to explore innovations and experiences and one, in the 
Eden district of the Western Cape, was on the list. While no mention is made of CG-
specific policies trialed during this pilot, the role of the FP, as lead on CG in the 
district health system is highlighted, with support from specialists at regional 
hospitals, GSAs and PCGCs.  
 
In addition to the above policy-mandated structures, many interviewees reported 
hosting or participating in additional regular meetings between colleagues in the 
same discipline, of similar or varying seniority, and between colleagues of varying 
disciplines who work in the same environment, where problem cases are discussed, 
positive and negative experiences shared, policies and protocols debated, etc. 
These serve to both improve clinical governance directly, as providers more 
regularly are presented with input on the subject, and indirectly, through the 
strengthening of the relationships between colleagues and the creation of a shared 
operational culture. 
 




Figure 1: Key Clinical Governance Structures 
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5.2. The Process of Clinical Governance  
 
The second objective of this study is to examine the process of clinical governance 
in the Western Cape - what are the relationships and pathways of information flow 
between levels and structures of the health system?  
 
By working through the process of each of the key structures identified in the 
previous discussion we begin to understand how CG takes place. 
 
5.2.1. M&M or M&E Meetings 
 
These are monthly, quarterly meetings held at facility or district level, where 
noteworthy cases are selected and presented to the meeting. Attendees usually 
comprise health care providers, managers and other invested parties and the 
intention is to understand why errors or successes (less often) occur, what system 
factors underlie these and discuss if and how these can be changed. 
 
This is an opportunity for collaborative problem-solving and shared learning and 
when conducted in a non-punitive way, are very effective at building confidence 
and moral. But as discussed above, this requires a skill set, clinical coaching, that 
not many practitioners have. 
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Relationships between colleagues within a facility or district are developed and 
information flows directly from clinical staff involved with a case to other clinical and 
non-clinical staff. 
 
5.2.2. Family Physicians and Family Medicine Registrars 
 
Family Physicians have become central to the process of clinical governance in the 
provincial district health system. They operate in multiple levels of the health 
system, moving information, knowledge and insight up and down, e.g. from clinic 
to Family Physician Forum to PCGC or management committee or vice versa, as well 
as across the health system, e.g. regional or provincial Family Physician Forums. 
 
They are mandated to develop and implement clinical governance in their region 
or district and do so by gathering health data and conducting clinical audits (against 
clinical guidelines), supporting caregivers and dealing with patient complaints, 
conducting ward rounds and/or folder reviews, supervise and train clinical and non-
clinical staff on evidence-based protocols, all while seeing patients at the same time. 
All of the family physicians interviewed reported enjoying the wide scope of their 
jobs but felt overwhelmed by the volume of work expected from them. 
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Some enjoyed their clinical role more, others the clinical governance and 
leadership role. One noted that it would be beneficial to the health system to allow 
those with an affinity for the latter to reduce their clinical scope and spend more 
time and resources creating a more robust quality improvement and clinical 
governance system. 
 
Outside of their clinical role, they are deeply involved in relationship building and 
information transfer, particularly the distribution of evidence-based guidelines and 
research findings. 
 
Family Medicine Registrars serve a similar role to Family Physicians, understandable 
given they are essentially Family Physicians in training. They also bring an additional 
academic aspect, as most are still tied into networks at the training institutions they 
are registered with. This allows the exchange of new ideas and information, and 
new ways of doing clinical practice and clinical governance, between academia and 
the “real world” and renders both stronger and more resilient. 
 
They receive training during their four-year registrar training that increases their 
competencies in key areas in addition to the clinical one. These include (1) 
developing their own leadership style, (2) facilitating a quality improvement cycle, 
(3) leading meetings looking at risk, e.g. M&E meetings, (3) teaching and training, 
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(4) familiarizing themselves with the process of clinical guideline implementation, 
(5) developing communication skills and (6) expanding on their ability to take 
routine information, e.g. the appropriate use of pharmaceuticals, and reflect upon 
this with their multidisciplinary teams, with the goal of improving the knowledge 
base of their teams and, thereby, clinical outcomes (i3). 
 
Family Physicians are also mandated to train and provide oversight to junior 
medical staff in their facility or district. One interviewee reported how fortnightly 
“sharing sessions” with junior doctors in the district had helped reduce mental 
health problems and improve moral, leading to improved clinical outcomes and 
staff retention.  
 
5.2.3. Co-Ordinating Clinicians, Level 2 Clinical Heads and Heads of General 
Specialist Services 
 
Similar to the role Family Physicians play in the district and regional levels (PHC and 
Level 1) of the health system, Co-ordinating Clinicians, Level 2 Heads and Heads of 
General Specialist Services (acting in Level 3) act as “system navigators” in higher 
levels (Level 2 and 3) of the health system. They are clinical specialists who 
understand the clinical, political and bureaucratic environments within which they 
operate, who the key stakeholders are and what evidence-based best practice is. 
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They serve to enable staff within their facilities to implement clinical governance and 
quality control strategies and to act as clinical governance advisors to colleagues in 
their own discipline across the province. 
 
They are effective because of the relationships they have throughout the health 
system, from executive management to facility managers, and they are also 
responsible for information transfer between structures and facilities through their 
participation in the structures of clinical governance described here, e.g. GSA or 
PCGC structures. 
 
5.2.4. Geographical Service Areas 
 
GSAs, and the Service Co-ordinating Working Groups (SCWGs) contained within 
them, were one of the few mandated forums for cross-disciplinary information 
sharing and engagement on the topic of clinical governance. They fostered 
relationship building by allowing participants to network between disciplines, 
facilities, structures and levels of the health system and similarly encourage the flow 
of information. 
 
For example, a discussion between an anesthetist and a theatre nurse on cost-
effective hand hygiene practices in a surgery-anaesthesia SCWG, when presented 
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to the broader GSA, allowed the outpatient Clinical Nurse Practitioner from 
gynaecology to learn a skill or process that improved quality of care of her and her 
team. The Level 2 Head or representative of the executive management structure 
passed this learning on to policy makers and this potentially become part of future 
policy on hand hygiene best practice. 
 
5.2.5. Provincial Clinical Governance Committees 
 
These provincial-level committees comprised of specialists, management 
structures related to that speciality and a family physician representative. There was 
one for every major speciality or discipline and they served to pull clinicians 
together from throughout the province to develop a common perspective on 
clinical governance matters related to their speciality. These could range from 
localizing national clinical protocols to discussing quality assessment audit 
outcomes. Generally, they met every three months, with some PCGCs functioning 
better than others. They viewed themselves more as advisors to policy makers than 
as policy makers themselves - even though they did have representation of 




PCGCs served to build relationships and share information between colleagues of 
the level of the same speciality but part of their challenge lay in the fact that 
specialists are not decision-makers at the facilities they operate in. Today, a 
collaborative management approach is prevalent and an anesthetist, for example, 
cannot comment on or commit to a course of action that will impact his or her 
theatre operations without the input of the theatre nurses and theatre management. 
PCGC’s were not mandated to share their discussions with non-speciality 
colleagues like GSAs are, and relied on the personal decision of individual 
participants on whether and how much information to share. 
 
But it appeared that the Family Physicians present on PCGCs had stepped into that 
role to some degree. One interviewee said they routinely fed back on the outcomes 
of their PCGC to their local clinician team and the Family Physician forum, who in 
turn disseminated important information further. For example, new asthma referral 
protocols from the NDoH were localized to the Western Cape by the pulmonary 
PCGC and this information was shared by the Family Physician to the facilities and 






5.2.6. Family Physician Forums 
 
Similar to PCGCs in that these forums are comprised on a single specialty - Family 
Physicians - but different in that they existed before they were put into the policy. 
They were created with the purpose of developing bonds between Family 
Physicians from across the region or province and sharing information and 
experiences to foster improved levels of care. They are self-driven, had access to 
power (through FPs who sat on PCGCs or engaged with management in other 
formal or informal channels) and worked so well that the policy makers incorporated 
them into the policy mix and gave them a direct reporting line to the executive 
managerial team. They both localize district and PHC-level policies and protocols 
passed down from national and provincial levels, as well as pass feedback and 
requests for new policy interventions upstream. 
 
Relationships between Family Physicians across a region or across the province are 
strengthened, creating networks for collaboration and innovation, and information 
Family Physician representatives on PCGCs, GSAs, academic institutions and other 
organisational structures is shared across the forum. This, in turn, is disseminated to 




5.3. The Outcomes 
 
The third and final objective of this study was to examine the impact of clinical 
governance initiatives on the quality of care and any KPIs associated with this. The 
KPIs associated with clinical governance and described in the Annual Performance 
Plans studied include: 
 
1. Mortality and Morbidity rates 
a. Per District, Regional and Central Hospital clusters 
b. Per individual hospital 
2. The number of customer survey questionnaires 
a. With positive feedback 




c. Resolved within 25 working days 
4. Number of Family Physicians and Family Medicine Registrars employed 
 
However, data was not accessible to the researcher to allow for assessment of 
whether positive or negative change was observed in these KPIs over time and if so, 




In the initial years after the end of apartheid the focus of policy makers was on 
desegregating the health system and creating one system that served all citizens 
equitably. With resources concentrated in urban centers, it would take time to 
create a network of care that covered the entire country and the quality of that care 
was secondary. As one interviewee put it: “In the 90s, one top manager said ‘I haven’t 
got time for this family medicine touchy-feely nonsense. I need people who can cut.’“ 
(i3). But management beliefs change, as personified in HealthCare 2030, where 
patient- and/or person-centeredness take center-stage as quality of care becomes 
a central focus.  
 
Another interviewee said that, given the contemporary literature on the value of CG 
structures on cost-reduction and quality improvement, “there is no need for policy 
makers to wait to add clinical governance into the system engineering mix. New 
health systems should be designed with them in place from the beginning... they are 
worth the resource spend” (i3). This is particularly important as South Africa 
embraces UHC and welcomes all the change that will accompany it. 
 
The health system envisioned in the NHI Bill, 2019, places a decentralized, district 
level, community-based organisational structure at the center of service provision, 
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coordinated centrally in Pretoria. The role of the current provincial departments of 
health and their existing district-level structures appears unclear from this 
document. The bill is very much focused on infrastructure changes and operational 
structure and gives little space to how the new health system will function once it is 
set up, not discussing topics like communication channels and clinical governance 
- in contrast to the comment by the interviewee described above. 
 
And while the bill lists the District Health Management Office as the administrative 
lead of clinical governance in the country, it says little about how clinical governance 
will look in practice or who will be responsible for it within the district teams being 
invested in. The NHI White Paper, 2017, places family physicians in this role and it 
waits to be seen if this will be carried over to the implementation of the NHI Bill. 
 
South African literature on family physicians in the public sector (Mash et al, 2016) 
and the field work for this study show how family physicians had successfully taken 
up the mantle of clinical governance leadership in the district health service. But 
consistent feedback from interviewees was that without a dedicated mandate, their 
time, resources and attention continued to be stretched between clinical and 
governance worlds, leading to less-than-ideal outcomes for both individual and 
intervention. It must be remembered that FPs were primarily clinicians who were 
trained in clinical governance. They were employed as clinicians in the HS and this 
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occupied the main portion of their time and attention. At the same time, none of the 
other participants in the multi-disciplinary district health team, incl. nurses, 
administrators, pharmacists, physios, etc., were equally trained in clinical 
governance. This created further tension for the FP because, as one interviewee put 
it: “family physicians may be leaders of clinical governance on the team, but they are 
not responsible for doing clinical governance.” FPs instead had the responsibility of 
guiding and upskilling teammates to action clinical governance in appropriate 
ways. This added teaching and ongoing CG coaching/training to their CG-related 
tasks within their facilities and/or sub-/districts. 
 
This did not cover the responsibility of coordinating CG within a district, region or 
province. At the time, some rural districts in the Western Cape had a coordinating 
FP who sat above facility level and coordinated across facilities and sub-districts. 
Others had Level 2 Heads and Heads of General Specialist Services who filled this 
“system navigator” role. All interviewees reported on the value of this role, over and 
above that of the meetings, forums and committees available to them, for keeping 
CG programmes integrated, coordinated and in action. This included the role of 
caring for the carers. As one interviewee put it: “if you want people to treat patients 
as people, they need to feel like they are also being seen as a person and not just a 
cog in the wheel” (i8). But there is no such role described in neither the NHI White 
paper nor NHI Bill. Instead, it speaks of practitioner accreditation by the OHSC and 
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penalties in terms of a change in accreditation status if quality audits didn’t meet 
expected standards. This, in turn, would prevent practitioners from consulting with 
patients and invoicing for services rendered. 
 
Another reason why more direction is needed from the NDoH in this regard is the 
current governance environment at facility or district level. Both national and 
provincial policies espouse a collaborative approach to leadership and governance 
and FPs are trained to emulate this during their 4-year registrarship. But they enter 
facilities or districts with operational managers who, for the most part, continue to 
run a “legacy-based, command-and-conquer leadership style” (i3). 
 
The relationship between clinical and corporate governance structures is 
fundamental to the successful implementation of CG policies. One interviewee 
stated that “it’s difficult for clinical governance to be done without support services 
working, like supply chain, HR, infrastructure, information systems...” (i4). More 
guidance is needed on how the two should relate to one another and where 
ownership and responsibility lies. Equally important, and in alignment with global 
CG literature, the responsibility for clinical governance should be included in the 
job descriptions for all top- and middle-level managers in the HS so that while they 
may not have the full skillset to create and implement programmes, they are 
obliged to support those who do. 
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Corporate managers have access to short courses on new leadership styles, but 
these serve mostly to highlight the need for change. “Ongoing in-service training or 
mentorship (following on from short courses) needs to support this new awareness 
in order for leadership styles to sustainably change” (i4). This should be built into the 
system operational manual. Family medicine researchers from the University of 
Stellenbosch one such trial in a district-level facility in Cape Town and saw “great 
enthusiasm for change but as soon as we stopped visiting them regularly, managers 
reverted to non-collaborative ways when under pressure” (i3). 
 
How clinical governance looks in practice also needs to evolve to reflect a 
contemporary people-centered and participative approach. Currently, the 
influence of the British analytical approach to clinical governance is evident, from 
how it was introduced to the province (“consultants flown in from London for 
massive workshops on a topic we didn’t know much about,” (i4)) and the frameworks 
drawn on to frame clinical governance policy in the province, which rely on the 
actions of clinical guideline adherence, M&E meetings and clinical audits. New 
approaches can and do incorporate some form of practice-level, peer-to-peer 
support structure (Campbell et al, 2008; Phillips et al, 2010). These structures are 
responsible for building leadership capacity at PHC level and “creating 
opportunities for reflection on one’s own professional practice and rendering clinical 
governance interventions locally relevant” (i8). 
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These structures are most often clinician-led but engage with other members of the 
local, multidisciplinary health intervention team as well as with regional and national 
networks, to encourage stronger teams, more adaptive needs-driven health policy, 
efficient funding spend, integrated information systems and sustainable 
improvement in the quality of health care delivered (Phillips et al, 2010). 
 
An example from this study was the management of CG in one local Western Cape 
district. Here, a FP was located within the office of the district manager, coordinating 
CG activities of FPs based at facilities and sub-district structures in their district. They 
engaged across all disciplinary divides and administration levels in a participative 
manner and also sat on provincial-level structures e.g. a PCGC. They had this to say 
of their experience of implanting CG with their team in a people-centered 
participative way: “It’s time to stop focusing just on continuous improvement and 
safeguarding high standards through continuous audits and M&E. It’s time to focus 
on creating an environment clinical governance can flourish, where people feel safe 
and open enough to engage with it constructively and, if not, to ask why.” (i4). 
 
Another stated that “good clinical governance depends on the strength of 
relationships between management and clinicians. If clinicians feel like they have a 
voice, they feel more empowered and more open to self-reflection and constructive 
criticism.” (i5). Interviewee i6 said she was “concerned by the current movement 
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apart between management and clinicians. Many in management began as 
clinicians and assume they still have that experience to help them understand our 
world. But the clinical environment is changing so fast, you need to remain present 
in the clinical world in order to understand its opportunities and challenges.” 
 
Interviewee i2 said he “felt so connected to HealthCare 2010 because we were 
consulted, and our feedback was heard. With HealthCare 2030 we were not. This 
leaves the department weaker and more vulnerable.” 
 
These comments describe a shift taking place, at the time, among some clinical 
governance practitioners in the province - a move from just focusing on the hard 
deliverables of clinical governance policy to including the softer interrelating 
aspects like communication and values, that facilitate the harder bits like clinical 
audits, M&E meetings and improved quality of care. An interesting question to 
explore in a future study is whether this shift is shared by FPs or clinical governance 
leads in other provinces and in other countries. Governance is a social practice that 
relies on relationships to create value for stakeholders (Bevir, 2013) - “you don’t 






Time restrictions limited the number of GSAs observed to 3 and the number of visits 
per GSA to 1. Observations over a series of meetings would have assisted in 
understanding the process of information flow and relationship building better. 
Most understandings of GSA functionality come from the in-depth interviews.  
 
Only 10 in-depth key informant interviews were conducted due to limitations of 
time. An executive managerial perspective would have been interesting to add into 
the mix of mostly clinicians. 
 
Without access to KPI data this study was unable to adequately answer the third 
question posed - how efficacy and functionality differ between the various 
interventions described in the literature and discussed during the interviews. 
 
This study was conducted in the Western Cape province only. This may influence 
the transferability of findings to other provinces and it is advised that the study be 




This study focuses largely on describing the structure of CG in the WCDoH over the 
20-year time period and provides a brief overview on the outcomes achieved 
through the implementation of these structures, viz. the differences in select health 
KPIs between the Western Cape and broader South Africa. However, it was not able 
to explore exhaustively the process of CG implementation due to restrictions on 
time and resources. This would be a valuable area for additional work following this 
paper as the author believes that it is in understanding the operationalization of 
policy and strategy in successful HSS case studies that important learnings may be 
gathered on how systems with similar challenges and pressures can be 






Clinical governance has grown to become key to both quality improvement 
measures and health system strengthening activities in the Western Cape. 
Designing a system around the provision of quality care places the patients’ needs 
centrally, as evidenced by the HealthCare 2030 policy.  
 
While the implementation of quality improvement or clinical governance policy 
requires a multidisciplinary approach, a lead is still required to ensure movement 
and momentum. Family physicians are the ideal candidate to champion clinical 
governance into the next iteration of the health system. In a study by Von Pressentin 
et al, 2018, the impact of family physicians in a variety of roles - care provider, 
consultant, trainer, leader, capacity builder - was highlighted as creating more value 
than other medical officers in similar district-based settings. This is interesting given 
that the new NHI Bill, 2019, places greater emphasis on a strong district health 
system. 
 
However, asking a family physician to continue to wear both clinician and clinical 
governance hats, and expecting greater output on both areas without adequate 
support from line managers and the multi-disciplinary team responsible for both 
clinical and governance outcomes, will only result in less than desired results. Their 
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role as clinical governance lead, and the value of a robust clinical governance 
programme, should be valued enough to make FPs spending more of their time in 
the clinical governance environment mandatory. 
 
In the new health system as envisaged by the NHI Bill, room should be made to 
continue with multidisciplinary clinical governance teams at facility/sub-district level 
and multi-disciplinary GSA meetings at district level. This will allow the 
dissemination of CG-related information throughout the HS and encourage a 
shared organisational culture towards clinical governance. 
 
Two additional factors that positively influence the outcomes of clinical governance 
initiatives and should be included in future policy include (1) the presence of a 
coordinating FP or clinician who moves information and knowledge between levels 
and structures of the HS and (2) the freedom for the process of clinical governance 
to evolve beyond the models defined in rigid high-level policies - when given the 
space for the process to be tailored to the stakeholders and conditions of a local 
environment, engagement with and outcomes of CG policies improve. 
 
These South African experiences contribute to the small pool of relevant experience 
from low- and middle-income countries reported in the international literature. 
Researchers in Egypt found that implementing CG through a multidisciplinary team 
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and developing stronger relationships between the executive and the clinical teams 
led to better quality outcomes (Abd El Fatah et al, 2019). Researchers in Burundi, 
Tajikistan and Yemen found that a multi-level approach provided improved CG 
outcomes in these countries (Goyet et al, 2019). And researchers in Iran found that 
both appropriate infrastructure and incorporation of stakeholder views and 
support, particularly family physicians, into CG policy implementation, led to better 
CG outcomes. These all support the overarching findings of this study that investing 
in building open and resilient communication channels across and through a health 
system and strengthening the relationships between all stakeholders in clinical 
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I (name) _____________________________________ declare that I have read and understood the 
Information Leaflet about the Clinical Governance in the Western Cape Department of 
Health Research Project. By signing this consent form, I am agreeing to take part in the 
research project. 
I understand that I can withdraw from the research process at any time if I feel that I can no 







I (name) ___________________________________ declare that I have explained the process of 
my research project to (Participants Name) ___________________________________________. I am 
convinced that s/he has understood everything satisfactorily, and has thus made an informed 
decision to take part in the study. S/He has the right to withdraw from the study at any time 











Research Title: Communication and collaboration, an exploration of clinical governance 
interventions in the Western Cape Department of Health over the past twenty years. 
 
Investigator: Professor Lucy Gilson, Head of Division: Health Policy and Systems, UCT 
Dr Yesheen Singh, email: yesheen@gmail.com 
You are kindly invited to participate in this research project. Please take some time to read 
the information below. It is important that you are completely satisfied and that you 
understand what the research is about and how you may be involved. 
 
What is this research study all about? 
In this study we would like to explore how clinical governance is written into policy, actioned 
in the real world and whether the difference between these two helps or hinders the efforts of 
the Department of Health to improve the quality of health care it seeks to provide to patients. 
Part of this project will be to explore the organisational culture of the WCDoH and its sub-units 
and how this influences clinical governance initiatives. 
 
Study Process: 
This study may involve you in two ways: 
1. We intend to observe existing governance meetings, forums, groups. This is purely to 
understand how these structures are set up, how they function and what they aim to 
do. This is in no way a personal evaluation exercise. 
2. We intend to select a sample of managers and policy makers to interview one-on-one, 
to gain further insight on the structure, process and outcomes of clinical governance 








How will you benefit? 
You will receive feedback in the form of a synopsis of the completed research that will assist 
you in gaining insight into what clinical governance is, why it is an important part of 
strengthening the health system in general and why it is an essential aspect of improving the 
quality of care provided. This information is helpful for both policy makers, managers and 
other stakeholders in the health system as we are all invested in creating a health system that 
is able to provide quality comprehensive, appropriate care to all citizens while maintaining 
cost-effectiveness and efficient resource allocation.  
You will also contribute towards a deeper understanding of what makes the health system in 
the Western Cape different, and in some areas better, than health systems in other provinces. 
This is invaluable information which will help to hopefully strengthen the health system and 
improve the quality of care provided to all South Africans. 
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Appendix D: Article Submission Guidelines 
 
Journal Selected: BMC Health Services Research 
 
Criteria 
Research articles should report on original primary research, but may report on 
systematic reviews of published research provided they adhere to the appropriate 
reporting guidelines which are detailed in our editorial policies. Please note that 
non-commissioned pooled analyses of selected published research will not be 
considered. Studies reporting descriptive results from a single institution will only 
be considered if analogous data have not been previously published in a peer 
reviewed journal and the conclusions provide distinct insights that are of relevance 
to a regional or international audience. 
 
BMC Health Services Research strongly encourages that all datasets on which the 
conclusions of the paper rely should be available to readers. We encourage authors 
to ensure that their datasets are either deposited in publicly available repositories 
(where available and appropriate) or presented in the main manuscript or 
additional supporting files whenever possible. Please see Springer 
Nature’s information on recommended repositories. Where a widely established 
research community expectation for data archiving in public repositories exists, 
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submission to a community-endorsed, public repository is mandatory. A list of data 
where deposition is required, with the appropriate repositories, can be found on 
the Editorial Policies Page. 
 
Preparing your manuscript 
The information below details the section headings that you should include in your 
manuscript and what information should be within each section. 
Please note that your manuscript must include a 'Declarations' section including all 
of the subheadings (please see below for more information). 
 
Title page 
The title page should: 
• present a title that includes, if appropriate, the study design e.g.:  
o "A versus B in the treatment of C: a randomized controlled trial", "X is 
a risk factor for Y: a case control study", "What is the impact of factor X 
on subject Y: A systematic review" 
o or for non-clinical or non-research studies a description of what the 
article reports 
• list the full names and institutional addresses for all authors  
o if a collaboration group should be listed as an author, please list the 
Group name as an author. If you would like the names of the individual 
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members of the Group to be searchable through their individual 
PubMed records, please include this information in the 
“Acknowledgements” section in accordance with the instructions 
below 
• indicate the corresponding author 
 
Abstract 
The Abstract should not exceed 350 words. Please minimize the use of 
abbreviations and do not cite references in the abstract. Reports of randomized 
controlled trials should follow the CONSORT extension for abstracts. The abstract 
must include the following separate sections: 
• Background: the context and purpose of the study 
• Methods: how the study was performed and statistical tests used 
• Results: the main findings 
• Conclusions: brief summary and potential implications 
• Trial registration: If your article reports the results of a health care 
intervention on human participants, it must be registered in an appropriate 
registry and the registration number and date of registration should be in 
stated in this section. If it was not registered prospectively (before enrolment 
of the first participant), you should include the words 'retrospectively 
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Three to ten keywords representing the main content of the article. 
 
Background 
The Background section should explain the background to the study, its aims, a 
summary of the existing literature and why this study was necessary or its 
contribution to the field. 
 
Methods 
The methods section should include: 
• the aim, design and setting of the study 
• the characteristics of participants or description of materials 
• a clear description of all processes, interventions and comparisons. Generic 
drug names should generally be used. When proprietary brands are used in 
research, include the brand names in parentheses 





This should include the findings of the study including, if appropriate, results of 
statistical analysis which must be included either in the text or as tables and figures. 
 
Discussion 
This section should discuss the implications of the findings in context of existing 
research and highlight limitations of the study. 
 
Conclusions 
This should state clearly the main conclusions and provide an explanation of the 
importance and relevance of the study reported. 
 
List of abbreviations 
If abbreviations are used in the text they should be defined in the text at first use, 
and a list of abbreviations should be provided. 
 
Declarations 
All manuscripts must contain the following sections under the heading 
'Declarations': 
• Ethics approval and consent to participate 
• Consent for publication 
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• Availability of data and materials 
• Competing interests 
• Funding 
• Authors' contributions 
• Acknowledgements 
• Authors' information (optional) 
Please see below for details on the information to be included in these sections. 
If any of the sections are not relevant to your manuscript, please include the heading 
and write 'Not applicable' for that section.  
Ethics approval and consent to participate 
Manuscripts reporting studies involving human participants, human data or human 
tissue must: 
• include a statement on ethics approval and consent (even where the need 
for approval was waived) 
• include the name of the ethics committee that approved the study and the 
committee’s reference number if appropriate 
Studies involving animals must include a statement on ethics approval and for 
experimental studies involving client-owned animals, authors must also include a 
statement on informed consent from the client or owner. 
See our editorial policies for more information. 
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If your manuscript does not report on or involve the use of any animal or human 
data or tissue, please state “Not applicable” in this section. 
Consent for publication 
If your manuscript contains any individual person’s data in any form (including any 
individual details, images or videos), consent for publication must be obtained from 
that person, or in the case of children, their parent or legal guardian. All 
presentations of case reports must have consent for publication. 
You can use your institutional consent form or our consent form if you prefer. You 
should not send the form to us on submission, but we may request to see a copy at 
any stage (including after publication). 
See our editorial policies for more information on consent for publication. 
If your manuscript does not contain data from any individual person, please state 
“Not applicable” in this section. 
Availability of data and materials 
All manuscripts must include an ‘Availability of data and materials’ statement. Data 
availability statements should include information on where data supporting the 
results reported in the article can be found including, where applicable, hyperlinks 
to publicly archived datasets analysed or generated during the study. By data we 
mean the minimal dataset that would be necessary to interpret, replicate and build 
upon the findings reported in the article. We recognise it is not always possible to 
share research data publicly, for instance when individual privacy could be 
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compromised, and in such instances data availability should still be stated in the 
manuscript along with any conditions for access. 
Data availability statements can take one of the following forms (or a combination 
of more than one if required for multiple datasets): 
• The datasets generated and/or analysed during the current study are 
available in the [NAME] repository, [PERSISTENT WEB LINK TO DATASETS] 
• The datasets used and/or analysed during the current study are available 
from the corresponding author on reasonable request. 
• All data generated or analysed during this study are included in this 
published article [and its supplementary information files]. 
• The datasets generated and/or analysed during the current study are not 
publicly available due [REASON WHY DATA ARE NOT PUBLIC] but are 
available from the corresponding author on reasonable request. 
• Data sharing is not applicable to this article as no datasets were generated 
or analysed during the current study. 
• The data that support the findings of this study are available from [third party 
name] but restrictions apply to the availability of these data, which were used 
under license for the current study, and so are not publicly available. Data are 
however available from the authors upon reasonable request and with 
permission of [third party name]. 
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• Not applicable. If your manuscript does not contain any data, please state 
'Not applicable' in this section. 
More examples of template data availability statements, which include examples of 
openly available and restricted access datasets, are available here. 
BioMed Central also requires that authors cite any publicly available data on which 
the conclusions of the paper rely in the manuscript. Data citations should include a 
persistent identifier (such as a DOI) and should ideally be included in the reference 
list. Citations of datasets, when they appear in the reference list, should include the 
minimum information recommended by DataCite and follow journal style. Dataset 
identifiers including DOIs should be expressed as full URLs. For example: 
Hao Z, AghaKouchak A, Nakhjiri N, Farahmand A. Global integrated drought 
monitoring and prediction system (GIDMaPS) data sets. figshare. 
2014. http://dx.doi.org/10.6084/m9.figshare.853801 
With the corresponding text in the Availability of data and materials statement: 
The datasets generated during and/or analysed during the current study are 
available in the [NAME] repository, [PERSISTENT WEB LINK TO DATASETS].[Reference 
number]  
If you wish to co-submit a data note describing your data to be published in BMC 
Research Notes, you can do so by visiting our submission portal. Data notes 
support open data and help authors to comply with funder policies on data sharing. 
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Co-published data notes will be linked to the research article the data support 
(example). 
For more information please email our Research Data Team. 
Competing interests 
All financial and non-financial competing interests must be declared in this section. 
See our editorial policies for a full explanation of competing interests. If you are 
unsure whether you or any of your co-authors have a competing interest please 
contact the editorial office. 
Please use the authors initials to refer to each authors' competing interests in this 
section. 
If you do not have any competing interests, please state "The authors declare that 
they have no competing interests" in this section. 
Funding 
All sources of funding for the research reported should be declared. The role of the 
funding body in the design of the study and collection, analysis, and interpretation 
of data and in writing the manuscript should be declared. 
Authors' contributions 
The individual contributions of authors to the manuscript should be specified in this 
section. Guidance and criteria for authorship can be found in our editorial policies. 
Please use initials to refer to each author's contribution in this section, for example: 
"FC analyzed and interpreted the patient data regarding the hematological disease 
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and the transplant. RH performed the histological examination of the kidney, and 
was a major contributor in writing the manuscript. All authors read and approved 
the final manuscript." 
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Please note that individual names may not be present in the PubMed record at the 
time a published article is initially included in PubMed as it takes PubMed additional 
time to code this information. 
Authors' information 
This section is optional. 
You may choose to use this section to include any relevant information about the 
author(s) that may aid the reader's interpretation of the article, and understand the 
standpoint of the author(s). This may include details about the authors' 
qualifications, current positions they hold at institutions or societies, or any other 
relevant background information. Please refer to authors using their initials. Note 
this section should not be used to describe any competing interests. 
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Footnotes can be used to give additional information, which may include the 
citation of a reference included in the reference list. They should not consist solely 
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